\-\ Texto\\:\\ \ \(0\)\
\-\ relative\\ to\\ the\\ cervical\\ and\\ upper\\ extremities\\ the\\ following\\ exam\\ was\\ performed\\ initially\\:\\ \\ she\\ is\\ 5\\‚\\Ä\\ô7\\‚\\Ä\\ù\\ tall\\ and\\ weighs\\ 330\\ lbs\\.\\ \\ blood\\ pressure\\ of\\ the\\ left\\ arm\\ in\\ the\\ seated\\ position\\ was\\ 138\\/86mmhg\\.\\ \\ \ \(0\)\
\-\ active\\ range\\ of\\ motion\\ of\\ the\\ cervical\\ spine\\ revealed\\ flexion\\ to\\ be\\ accomplished\\ to\\ 40o\\/50o\\,\\ right\\ rotation\\ to\\ 40o\\/80o\\,\\ left\\ rotation\\ to\\ 40o\\/80o\\,\\ left\\ lateral\\ bending\\ to\\ 25o\\/45o\\,\\ right\\ lateral\\ bending\\ to\\ 25o\\/45o\\ and\\ extension\\ to\\ 25o\\/60o\\.\\ \\ she\\ reported\\ neck\\ pain\\ extending\\ to\\ the\\ left\\ shoulder\\ during\\ left\\ lateral\\ bending\\.\\ \\ during\\ extension\\ she\\ reported\\ tightness\\ and\\ pain\\ in\\ the\\ neck\\.\\ \\ \ \(0\)\
\-\ the\\ bicep\\ reflexes\\ were\\ graded\\ 1\\/4\\ bilaterally\\.\\ \\ the\\ triceps\\ reflex\\ was\\ graded\\ 2\\/4\\ on\\ the\\ left\\ and\\ 1\\/4\\ on\\ the\\ right\\.\\ \\ cervical\\ distraction\\ was\\ unremarkable\\.\\ \\ cervical\\ compression\\ testing\\ produced\\ report\\ of\\ neck\\ pain\\ extending\\ down\\ the\\ left\\ upper\\ extremity\\ to\\ the\\ fingers\\.\\ \\ active\\ range\\ of\\ motion\\ of\\ the\\ shoulders\\ was\\ within\\ normal\\ limits\\.\\ \\ muscle\\ strengths\\ of\\ the\\ upper\\ extremities\\ was\\ within\\ normal\\ limits\\ bilaterally\\.\\ \\ grip\\ strength\\ was\\ tested\\ using\\ a\\ jamar\\ dynamometer\\.\\ the\\ right\\ hand\\ tested\\ to\\ 70\\ lbs\\ and\\ the\\ left\\ hand\\ tested\\ 45\\ lbs\\.\\ \\ he\\ reports\\ being\\ right\\ hand\\ dominant\\.\\ \\ \\ \ \(0\)\
\-\ general\\ exam\\ significant\\ for\\ obesity\\.\ \(0\)\
\-\ 18\\ months\\ later\\ the\\ the\\ neurologist\\ performed\\ an\\ ophthalmic\\ exam\\ which\\ \\ revealed\\ bilateral\\ optic\\ disc\\ swelling\\,\\ while\\ visual\\ fields\\ and\\ extraocular\\ motility\\ were\\ intact\\.\ \(0\)\
\-\ indices\\ performed\\ within\\ a\\ month\\ of\\ this\\ publication\\:\ \(0\)\
\-\ revised\\ oswestry\\ low\\ back\\ pain\\ disability\\ questionnaire\\ and\\ scored\\ 46\\%\\.\ \(0\)\
\-\ fairbanks\\ j\\,\\ davies\\ j\\,\\ et\\ al\\.\\ the\\ oswestry\\ low\\ back\\ pain\\ disability\\ questionnaire\\.\\ physiother\\ 1980\\;\\ 66\\(18\\)\\:271\\-273\ \(0\)\
\-\ neck\\ disability\\ index\\ questionnaire\\ and\\ scored\\ 34\\%\\.\ \(0\)\
\-\ vernon\\ h\\,\\ mior\\ s\\.\\ the\\ neck\\ disability\\ index\\:\\ a\\ study\\ of\\ reliability\\ and\\ validity\\.\\ j\\ manpipulative\\ physiol\\ ther\\ 1991\\;14\\:409\\-415\\.\ \(0\)\
\-\ activities\\ discomfort\\ scale\\ and\\ scored\\ 24\\%\\.\\ \ \(0\)\
\-\ turner\\ ja\\,\\ robinson\\ j\\.\\ mccreary\\ cp\\.\\ chronic\\ low\\ back\\ pain\\:\\ predicting\\ response\\ to\\ nonsurgical\\ treatment\\.\\ arch\\ phys\\ med\\ rehabil\\ 1983\\;\\ 64\\:560\\-563\ \(0\)\
\-\ following\\ computerized\\ range\\ of\\ motion\\ evaluation\\ of\\ the\\ cervical\\ spine\\ within\\ a\\ month\\ of\\ this\\ publication\\:\\ \\ active\\ range\\ of\\ motion\\ of\\ the\\ cervical\\ spine\\ was\\ performed\\.\\ during\\ flexion\\,\\ extension\\,\\ and\\ left\\ lateral\\ bending\\ patient\\ denied\\ having\\ neck\\ pain\\ as\\ well\\ as\\ upper\\ extremity\\ pain\\.\\ during\\ left\\ and\\ right\\ rotation\\ patient\\ reported\\ increased\\ neck\\ pain\\ extending\\ into\\ the\\ bilateral\\ shoulders\\.\\ during\\ right\\ lateral\\ bending\\ patient\\ reported\\ increased\\ right\\ neck\\ pain\\ into\\ the\\ right\\ shoulder\\.\\ \ \(0\)\
\-\ algometry\\:\\ \ \(0\)\
\-\ hyperalgesia\\ was\\ noted\\ in\\ the\\ left\\ levator\\ scapula\\,\\ left\\ deltoid\\,\\ \\&\\ left\\/right\\ lumbar\\ paraspinals\\ \\(2\\ finger\\ width\\ from\\ midline\\,\\ l4\\ level\\)\\ to\\ algometry\\ testing\\.\\ \ \(0\)\
\-\ fischer\\ aa\\.\\ pressure\\ algometry\\ over\\ normal\\ muscles\\.\\ \\ standard\\ values\\,\\ validity\\ and\\ reproducibility\\ of\\ pressure\\ threshold\\.\\ \\ pain\\ 1987\\;30\\:115\\-26\\.\ \(0\)\
\-\ emg\\ studies\\ of\\ the\\ upper\\ and\\ lower\\ extremities\\ did\\ not\\ reveal\\ radiculopathy\\.\ \(0\)\
\-\ following\\ the\\ results\\ of\\ the\\ ophthalmic\\ exam\\,\\ ct\\ scan\\ of\\ brain\\ showed\\ no\\ mass\\ lesion\\ and\\ a\\ lumbar\\ puncture\\ was\\ performed\\.\\ the\\ lumbar\\ puncture\\ had\\ an\\ opening\\ pressure\\ of\\ 40cmh2o\\.\\ upper\\ limit\\ of\\ normal\\ for\\ opening\\ pressure\\ is\\ 25cmh2o\\,\\ and\\ this\\ increased\\ intracranial\\ pressure\\ resulted\\ in\\ the\\ diagnosis\\ of\\ papilledema\\ with\\ pseudotumor\\ cerebri\\.\\ \\ the\\ patient\\ was\\ started\\ on\\ acetazolamide\\ 250mg\\ qd\\,\\ increased\\ gradually\\ to\\ 2\\ bid\\ over\\ a\\ month\\.\\ medication\\ course\\ was\\ over\\ 3\\ months\\.\\ the\\ lumbar\\ puncture\\ itself\\ was\\ therapeutic\\ with\\ a\\ closing\\ pressure\\ of\\ 19cmh2o\\.\\ csf\\ studies\\ returned\\ with\\ no\\ abnormalities\\.\\ patient\\ was\\ counseled\\ on\\ weight\\ control\\,\\ including\\ physical\\ activity\\ and\\ diet\\.\\ she\\ was\\ advised\\ that\\ controlling\\ her\\ body\\ weight\\ could\\ help\\ or\\ even\\ resolve\\ her\\ condition\\.\\ she\\ was\\ referred\\ and\\ followed\\ by\\ both\\ ophthalmology\\ and\\ neurology\\ with\\ documented\\ ophthalmic\\ exams\\ every\\ 4\\ weeks\\.\\ at\\ the\\ end\\ of\\ 3\\ months\\ follow\\ up\\ ophthalmic\\ exam\\ revealed\\ resolution\\ of\\ papilledema\\.\ \(0\)\
\-\ cervical\\ mri\\ one\\ month\\ following\\ the\\ mva\\:\\ alignment\\ of\\ the\\ cervical\\ vertebrae\\ is\\ maintained\\ in\\ neutral\\ sagittal\\ imaging\\.\\ \\ no\\ instability\\ is\\ demonstrated\\ on\\ sagittal\\ flexion\\ and\\ extension\\ imaging\\.\\ \\ disc\\ spaces\\ are\\ relatively\\ maintained\\.\\ \\ there\\ is\\ no\\ evidence\\ for\\ focal\\ marrow\\ replacement\\ or\\ marrow\\ edema\\ of\\ the\\ cervical\\ vertebrae\\.\\ \\ a\\ hemangioma\\ is\\ noted\\ at\\ the\\ c4\\ vertebral\\ body\\.\\ the\\ craniocervical\\ junction\\ is\\ unremarkable\\.\\ \\ there\\ is\\ no\\ evidence\\ for\\ focal\\ abnormal\\ signal\\ or\\ focal\\ expansion\\ of\\ the\\ cervical\\ spinal\\ cord\\.\ \(0\)\
\-\ c2\\-3\\:\\ \\ there\\ is\\ no\\ evidence\\ for\\ central\\ canal\\ or\\ foraminal\\ stenosis\\.\\ \\ no\\ significant\\ intervertebral\\ disc\\ pathology\\ is\\ evident\\.\ \(0\)\
\-\ c3\\-4\\:\\ \\ there\\ is\\ no\\ evidence\\ for\\ central\\ canal\\ or\\ foraminal\\ stenosis\\.\\ \\ no\\ significant\\ intervertebral\\ disc\\ pathology\\ is\\ evident\\.\ \(0\)\
\-\ c4\\-5\\:\\ there\\ is\\ no\\ evidence\\ for\\ central\\ canal\\ or\\ foraminal\\ stenosis\\.\\ \\ no\\ significant\\ intervertebral\\ disc\\ pathology\\ is\\ evident\\.\ \(0\)\
\-\ c5\\-6\\:\\ \\ there\\ is\\ no\\ evidence\\ for\\ central\\ canal\\ or\\ right\\ sided\\ foraminal\\ stenosis\\.\\ \\ a\\ minimal\\ degree\\ of\\ left\\ sided\\ foraminal\\ stenosis\\ is\\ noted\\ secondary\\ to\\ asymmetric\\ uncovertebral\\ and\\ facet\\ joint\\ degenerative\\ changes\\.\ \(0\)\
\-\ c6\\-7\\:\\ \\ there\\ is\\ no\\ evidence\\ for\\ central\\ canal\\ or\\ foraminal\\ stenosis\\.\\ \\ no\\ significant\\ intervertebral\\ disc\\ pathology\\ is\\ evident\\.\ \(0\)\
\-\ c7\\-t1\\:\\ \\ there\\ is\\ no\\ evidence\\ for\\ central\\ canal\\ or\\ foraminal\\ stenosis\\.\\ \\ no\\ significant\\ intervertebral\\ disc\\ pathology\\ is\\ evident\\.\ \(0\)\
\-\ no\\ significant\\ accentuation\\ of\\ intervertebral\\ disc\\ pathology\\ is\\ noted\\ upon\\ sagittal\\ flexion\\ and\\ extension\\ imaging\\.\\ \\ \ \(0\)\
\-\ impression\\:\\ \\ \ \(0\)\
\-\ 1\\.\\	c5\\-6\\:\\ \\ there\\ is\\ no\\ evidence\\ for\\ central\\ canal\\ or\\ right\\ sided\\ foraminal\\ stenosis\\.\\ \\ a\\ minimal\\ degree\\ of\\ left\\ sided\\ foraminal\\ stenosis\\ is\\ noted\\ secondary\\ to\\ asymmetric\\ uncovertebral\\ and\\ facet\\ joint\\ degenerative\\ changes\\.\ \(0\)\
\-\ 2\\.\\	these\\ findings\\ are\\ consistent\\ with\\ phase\\ i\\-\\ ii\\ pathophysiology\\ of\\ the\\ chiropractic\\ clinical\\ diagnosis\\ of\\ vertebral\\ subluxation\\ complex\\.\\ \\ clinical\\ correlation\\ is\\ recommended\\.\\ \ \(0\)\
\-\ 3\\.\\	if\\ further\\ evaluation\\ of\\ radicular\\ symptoms\\ or\\ foraminal\\ pathology\\ is\\ required\\ correlation\\ with\\ emg\\ and\\/or\\ nerve\\ conduction\\ studies\\ would\\ be\\ helpful\\.\\ \ \(0\)\
\-\ stereo\\ color\\ photographs\\ of\\ the\\ optic\\ discs\\ showed\\ circumferential\\ swelling\\ of\\ the\\ optic\\ discs\\,\\ with\\ some\\ obscuration\\ of\\ major\\ vessels\\ as\\ they\\ exit\\ the\\ disc\\.\\ these\\ were\\ consistent\\ with\\ frisen\\ stage\\ iii\\ \\-\\ iv\\ papilledema\\.\ \(0\)\
\-\ ct\\ of\\ the\\ orbits\\ with\\ and\\ without\\ contrast\\ was\\ unremarkable\\.\ \(0\)\
\-\ ct\\ of\\ the\\ brain\\ with\\ and\\ without\\ contrast\\ was\\ read\\ as\\ a\\ normal\\ study\\.\ \(0\)\
\-\ pseudotumor\\ cerebri\\ and\\ papilledema\ \(0\)\
\-\ 1\\ \\‚\\Ä\\ì\\ cns\\ space\\ occupying\\ lesion\ \(0\)\
\-\ 2\\ \\‚\\Ä\\ì\\ trauma\ \(0\)\
\-\ 3\\ \\‚\\Ä\\ì\\ pseudotumor\\ cerebri\ \(0\)\
\-\ 4\\ \\‚\\Ä\\ì\\ migraine\ \(0\)\
\-\ 5\\ \\‚\\Ä\\ì\\ medication\\ induced\ \(0\)\
\-\ 6\\ \\-\\ infection\\/inflammatory\ \(0\)\
\-\ 27\\ year\\ old\\ white\\ female\\,\\ \\(licensed\\ practical\\ nurse\\)\\ with\\ a\\ history\\ of\\ mva\\ presented\\ to\\ the\\ chiropractic\\ office\\ 6\\ days\\ after\\ the\\ episode\\.\\ \\ \\ \\ she\\ was\\ the\\ belted\\ driver\\ of\\ a\\ moving\\ vehicle\\ with\\ her\\ seat\\ belt\\ attached\\ when\\ another\\ vehicle\\ struck\\ the\\ vehicle\\ she\\ was\\ in\\ on\\ the\\ passenger\\ side\\ in\\ a\\ t\\-bone\\ manner\\.\ \(0\)\
\-\ she\\ reports\\ being\\ diagnosed\\ prior\\ to\\ the\\ mva\\ with\\:\\ fibromyalgia\\,\\ rheumatoid\\ arthritis\\,\\ bipolar\\ disorder\\,\\ ibs\\ and\\ migraines\\.\\ additional\\ history\\ significant\\ for\\ hospitalizations\\ for\\ depression\\,\\ zanaflex\\ overdose\\,\\ and\\ morphine\\ overdose\\.\\ \\ she\\ reports\\ taking\\ the\\ following\\ medications\\ prior\\ to\\ the\\ mva\\:\\ oxycodone\\ 5mg\\,\\ oxycontin\\ 10mg\\,\\ neurontin\\ 300mg\\,\\ lexapro\\ 40mg\\,\\ klonopin\\ 1mg\\,\\ predisone\\ 5mg\\,\\ seroquel\\ xr\\ 300\\ mg\\,\\ abilify\\ 30mg\\,\\ methocarbamol\\ 75mg\\,\\ vynase\\ 50\\ mg\\,\\ motrin\\ 800\\ mg\\ and\\ pro\\-air\\ inhaler\\.\\ \ \(0\)\
\-\ she\\ had\\ been\\ having\\ headaches\\ and\\ migraines\\ since\\ her\\ mva\\,\\ but\\ notes\\ recent\\ headaches\\ being\\ different\\ from\\ her\\ usual\\ migraines\\,\\ being\\ localized\\ to\\ her\\ bifrontal\\ and\\ retroorbital\\ regions\\.\\ the\\ headache\\ was\\ constant\\ and\\ described\\ as\\ a\\ pressure\\ pushing\\ from\\ behind\\ her\\ eyes\\.\\ she\\ reported\\ her\\ other\\ chronic\\ conditions\\ as\\ being\\ managed\\ and\\ unchanged\\.\\ \\ approaching\\ 18\\ months\\ later\\ she\\ reported\\ blurry\\ vision\\.\\ \ \(0\)\
\-\ current\\ medications\\:\\ \ \(0\)\
\-\ sumatriptan\\ 100mg\\ 1\\ tab\\ prn\\ headache\\,\\ geodon\\ 60mg\\ 2\\ caps\\ qd\\,\\ deplin\\ 15mg\\ 1\\ cap\\ qd\\,\\ neurontin\\ 300mg\\ 1\\ cap\\ tid\\,\\ klonipin\\ 1mg\\ 1\\ tab\\ qd\\,\\ celexa\\ 20mg\\ 1\\ \\¬\\Ω\\ tabs\\ qd\\,\\ linzess\\ 145mcg\\ 1\\ cap\\ qd\\,\\ prednisone\\ 5mg\\ 1\\ tab\\ qd\\,\\ bentyl\\ 10mg\\ 2\\ caps\\ prn\\,\\ zanaflex\\ 4\\ mg\\ 2\\ tabs\\ q8h\\,\\ tramadol\\ 50\\ mg\\ 1\\ tab\\ q6h\\,\\ protonix\\ 40mg\\ 1\\ tab\\ qd\\,\\ detrol\\ 4mg\\ 1\\ cap\\ qd\\,\\ imuran\\ as\\ directed\ \(0\)\
\-\ allergies\\:\\ levoquin\ \(0\)\
\-\ on\\ her\\ second\\ visit\\ for\\ chiropractic\\ care\\ \\(8\\ days\\ after\\ the\\ accident\\)\\,\\ she\\ reported\\ that\\ she\\ had\\ consulted\\ her\\ pcp\\,\\ was\\ sent\\ to\\ a\\ neurologist\\ for\\ pain\\ management\\ and\\ had\\ an\\ appointment\\ with\\ her\\ rheumatolgoist\\ that\\ she\\ had\\ seen\\ prior\\ to\\ the\\ accident\\.\\ \\ within\\ a\\ month\\ she\\ found\\ herself\\ to\\ be\\ constipated\\ and\\ was\\ going\\ to\\ her\\ obgyn\\ for\\ evaluation\\.\\ \\ she\\ then\\ reports\\ going\\ to\\ a\\ urologist\\ for\\ further\\ evaluation\\ within\\ 2\\ months\\ following\\ the\\ mva\\.\\ \\ due\\ to\\ neck\\ pain\\ and\\ discomfort\\ radiating\\ to\\ the\\ shoulders\\ she\\ was\\ sent\\ for\\ mri\\ of\\ the\\ cervical\\ spine\\ by\\ her\\ chiropractor\\.\\ \\ \\ approximately\\,\\ 3\\ months\\ after\\ the\\ mva\\ she\\ does\\ report\\ increased\\ depression\\ as\\ a\\ result\\ of\\ her\\ injuries\\ and\\ indicates\\ increased\\ headache\\ symptoms\\.\\ she\\ was\\ referred\\ by\\ her\\ treating\\ doctor\\ of\\ chiropractic\\ who\\ acted\\ as\\ the\\ primary\\ care\\ doctor\\ for\\ the\\ mva\\ case\\ to\\:\\ another\\ pain\\ management\\ specialist\\ as\\ she\\ preferred\\ another\\,\\ an\\ orthopedic\\ surgeon\\,\\ another\\ neurologist\\,\\ a\\ neuropsychiatrist\\,\\ massage\\ therapist\\ and\\ for\\ electrodiagnositic\\ evaluation\\.\\ \\ she\\ had\\ her\\ first\\ prolotherapy\\ treatment\\ from\\ the\\ physiatric\\ specialist\\ 7\\ months\\ following\\ the\\ mva\\ which\\ then\\ continued\\ on\\ a\\ 1x\\/month\\ basis\\ to\\ the\\ neck\\.\\ \\ \\ the\\ neuropsychiatrist\\ diagnosed\\ ptsd\\ from\\ the\\ mva\\,\\ prescribed\\ giodon\\.\\ \\ such\\ prescription\\ was\\ approximately\\ one\\ year\\ following\\ the\\ mva\\ which\\ helped\\ and\\ later\\ he\\ increased\\ the\\ dosage\\ of\\ such\\.\\ \\ she\\ also\\ went\\ to\\ a\\ counselor\\ for\\ her\\ condition\\.\\ \\ \\ about\\ 9\\-10\\ months\\ after\\ the\\ mva\\ she\\ reports\\ applying\\ for\\ ssd\\ and\\ 13\\ months\\ following\\ the\\ mva\\ was\\ denied\\ ssd\\.\\ \\ the\\ neuropsychiatrist\\ then\\ added\\ celexa\\ to\\ her\\ medications\\ approximately\\ 15\\ months\\ post\\-mva\\.\\ \\ approximately\\,\\ 18\\ months\\ after\\ the\\ mva\\ she\\ was\\ then\\ diagnosed\\ as\\ having\\ increased\\ csf\\ pressure\\ causing\\ her\\ to\\ have\\ headaches\\.\\ \\ \\ she\\ was\\ then\\ referred\\ by\\ the\\ neurologist\\ to\\ an\\ ophthamologist\\ who\\ performed\\ fundoscopic\\ evaluation\\.\\ \\ from\\ there\\ she\\ was\\ referred\\ to\\ a\\ hospital\\ to\\ perform\\ spinal\\ tap\\ evaluation\\.\\ \\ the\\ time\\ period\\ between\\ the\\ diagnosis\\ by\\ the\\ opthamologist\\ for\\ spinal\\ tap\\ procedure\\ was\\ less\\ than\\ 2\\ weeks\\.\\ \\ the\\ repeat\\ fundoscopic\\ evaluations\\ were\\ performed\\ approximately\\ 2\\ months\\ following\\ the\\ spinal\\ tap\\ and\\ the\\ prescription\\ of\\ azetazolamide\\.\ \(0\)\
\-\ she\\ did\\ describe\\ blurriness\\ of\\ vision\\ about\\ the\\ time\\ frame\\ surrounding\\ the\\ diagnosis\\ and\\ subsequent\\ treatment\\ of\\ spinal\\ tap\\ and\\ azetazolamide\\.\\ \\ such\\ blurriness\\ then\\ subsided\\ after\\ this\\ treatment\\.\\ \ \(0\)\
\-\ she\\ did\\ receive\\ a\\ cervical\\ mri\\ following\\ her\\ mva\\ demonstrating\\ spinal\\ injury\\ and\\ has\\ had\\ followup\\ with\\ her\\ chiropractor\\.\ \(0\)\
\-\ case\\ contributors\\:\ \(0\)\
\-\ christopher\\ doan\\ msiv\\,\\ randall\\ loftus\\,\\ md\\;\\ joanna\\ garvey\\,\\ dc\\;\\ robert\\ lutnick\\,\\ md\\;\\ scott\\ croce\\,\\ dc\\;\\ gary\\ smith\\,\\ dc\\;\\ krishnan\\ kartha\\,\\ md\\;\\ joseph\\ serghany\\,\\ md\\;\\ charles\\ tirone\\,\\ md\\,\\ vaseem\\ iqbal\\,\\ md\\;\\ jennifer\\ sperrazza\\,\\ dc\\;\\ jeffrey\\ lieberman\\,\\ md\\;\\ geoffrey\\ gerow\\,\\ dc\\.\\ \ \(0\)\
\-\ the\\ cause\\ of\\ iih\\ as\\ the\\ name\\ describes\\ is\\ nonspecific\\.\\ \\ as\\ such\\,\\ the\\ history\\ section\\ of\\ this\\ case\\ was\\ enumerated\\ more\\ fully\\ to\\ understand\\ the\\ timeline\\ of\\ development\\ of\\ papilledema\\.\\ \\ iih\\ does\\ not\\ often\\ occur\\ without\\ papilledema\\,\\ \\(digre\\)\\.\\ although\\ papilledema\\ usually\\ occurs\\ bilaterally\\,\\ it\\ is\\ possible\\ to\\ have\\ asymmetric\\ papilledema\\.\\ \\ in\\ this\\ case\\ study\\ you\\ can\\ see\\ where\\ one\\ eye\\ is\\ a\\ frisen\\ stage\\ 3\\ and\\ the\\ other\\ is\\ closer\\ to\\ stage\\ 4\\ on\\ the\\ initial\\ evaluations\\.\\ \\ \\ prior\\ to\\ 2004\\ the\\ diagnosis\\ of\\ iih\\ required\\ the\\ diagnosis\\ of\\ papilledema\\ via\\ the\\ modified\\ dandy\\ criteria\\.\\ \\ \\ a\\ variant\\,\\ idiopathic\\ intracranial\\ hypertension\\ without\\ papilledema\\ \\(iihwop\\)\\ was\\ included\\ in\\ 2004\\ within\\ the\\ international\\ headache\\ society\\ classification\\ criteria\\.\\ \\ such\\ has\\ been\\ documented\\ in\\ the\\ literature\\ since\\ then\\.\\ \\ there\\ are\\ two\\ types\\ of\\ iih\\;\\ acute\\ and\\ chronic\\.\\ \\ our\\ patient\\ does\\ not\\ fit\\ the\\ acute\\ \\ category\\ as\\ she\\ did\\ not\\ demostrate\\ acute\\ findings\\ of\\ intracranial\\ bleeding\\ or\\ brain\\ swelling\\ following\\ the\\ mva\\.\\ \\ chronic\\ iih\\ is\\ characterized\\ by\\ increased\\ cerebrospinal\\ fluid\\ \\(csf\\)\\ pressure\\ which\\ can\\ occur\\ without\\ a\\ detectable\\ cause\\ \\(idiopathic\\ intracranial\\ hypertension\\)\\ or\\ be\\ triggered\\ by\\ an\\ identifiable\\ cause\\ such\\ as\\ an\\ underlying\\ disease\\ or\\ disorder\\,\\ injury\\,\\ drug\\ or\\ cerebral\\ blood\\ clot\\ \\(secondary\\ intracranial\\ hypertension\\)\\.\\ \\ our\\ patient\\ does\\ fit\\ the\\ second\\ classification\\ of\\ iih\\ with\\ vision\\ changes\\ occurring\\ 18\\ months\\ following\\ the\\ mva\\.\\ \\ \\ chronic\\ mild\\ papilledema\\ can\\ occur\\ for\\ months\\ or\\ years\\ and\\ without\\ significant\\ loss\\ of\\ vision\\.\\ \\ \\ however\\,\\ when\\ such\\ manifests\\ itself\\ action\\ is\\ imperative\\ or\\ there\\ may\\ be\\ permanent\\ damage\\.\\ \\ in\\ this\\ case\\ the\\ patient\\ was\\ diagnosed\\ with\\ papilledema\\ 18\\ months\\ following\\ the\\ mva\\ and\\ where\\ the\\ mva\\ may\\ have\\ caused\\ sufficient\\ trauma\\ to\\ set\\ the\\ stage\\ for\\ slow\\ chronic\\ development\\ of\\ iih\\.\\ \\ \\ the\\ neuropsychiatrist\\ made\\ the\\ causally\\ related\\ diagnosis\\ to\\ the\\ mva\\ of\\ ptsd\\.\\ \\ \\ such\\ a\\ disorder\\ is\\ accompanied\\ by\\ anxiety\\.\\ \\ our\\ patient\\ found\\ that\\ following\\ the\\ mva\\ she\\ was\\ not\\ able\\ to\\ drive\\ herself\\ to\\ the\\ office\\ and\\ her\\ mother\\ had\\ to\\ drive\\ her\\ due\\ to\\ such\\ anxiety\\.\\ \\ patients\\ with\\ anxiety\\ have\\ an\\ increased\\ incidence\\ of\\ iih\\ \\(kessler\\)\\.\\ \\ \\ it\\ is\\ possible\\ then\\ that\\ the\\ ptsd\\ may\\ have\\ served\\ to\\ contribute\\ to\\ the\\ iih\\ and\\ papilledema\\ conditions\\.\\ \\ late\\ onset\\ papilledema\\ related\\ to\\ spine\\ injury\\ has\\ been\\ reported\\,\\ \\(catz\\)\\.\\ \\ \\ however\\,\\ the\\ latency\\ reported\\ is\\ not\\ nearly\\ as\\ long\\ as\\ in\\ the\\ catz\\ et\\ al\\ publication\\ and\\ spinal\\ injury\\ in\\ this\\ case\\ is\\ not\\ felt\\ to\\ be\\ principal\\ problem\\ in\\ the\\ development\\ of\\ papilledema\\.\\ \\ the\\ concept\\ of\\ latent\\ papilledema\\ does\\ underscore\\ the\\ value\\ of\\ routine\\ repeat\\ opthalmoscopic\\ examinations\\ following\\ spinal\\ injury\\ to\\ detect\\ changes\\ characteristic\\ of\\ iicp\\.\\ \\ \ \(0\)\
\-\ she\\ does\\ however\\,\\ have\\ many\\ other\\ factors\\ outside\\ of\\ the\\ mva\\ that\\ may\\ be\\ related\\ to\\ the\\ iih\\.\\ \\ she\\ has\\ an\\ extensive\\ medical\\ history\\,\\ with\\ multiple\\ chronic\\ conditions\\ that\\ contribute\\ to\\ pain\\ and\\ headache\\,\\ including\\ vision\\ changes\\.\\ for\\ example\\,\\ progression\\ of\\ the\\ patient\\"s\\ rheumatoid\\ arthritis\\ can\\ present\\ with\\ ocular\\ manifestations\\.\\ her\\ numerous\\ medications\\ also\\ complicate\\ the\\ clinical\\ picture\\ with\\ their\\ possible\\ side\\ effects\\,\\ especially\\ the\\ psychiatric\\ medications\\ and\\ corticosteroids\\.\\ \ \(0\)\
\-\ the\\ optic\\ disc\\ swelling\\,\\ papilledema\\,\\ on\\ fundoscopic\\ exam\\ by\\ the\\ neurologist\\ and\\ subsequently\\ the\\ opthamolgist\\ directed\\ the\\ evaluation\\ toward\\ intracranial\\ hypertension\\ \\(ih\\)\\.\\ \\ ih\\ was\\ confirmed\\ on\\ spinal\\ tap\\ evaluation\\.\\ \\ \ \(0\)\
\-\ the\\ ct\\ scans\\ of\\ the\\ brain\\ and\\ orbits\\ were\\ performed\\ initially\\,\\ since\\ a\\ mass\\ lesion\\ would\\ not\\ only\\ provide\\ a\\ diagnosis\\ but\\ contraindicate\\ other\\ procedures\\ such\\ as\\ a\\ lumbar\\ puncture\\.\\ the\\ negative\\ findings\\ on\\ ct\\ scan\\ ruled\\ out\\ a\\ cns\\ mass\\,\\ and\\ combined\\ with\\ the\\ patient\\"s\\ lack\\ of\\ recent\\ trauma\\ made\\ a\\ hematoma\\ or\\ hemorrhage\\ from\\ trauma\\ causing\\ increased\\ icp\\ unlikely\\.\\ the\\ results\\ from\\ the\\ lumbar\\ puncture\\ then\\ confirmed\\ increased\\ icp\\.\\ with\\ no\\ overt\\ cns\\ lesion\\ and\\ no\\ evidence\\ of\\ infection\\ or\\ flareup\\ of\\ her\\ inflammatory\\ disorders\\,\\ the\\ diagnosis\\ of\\ pseudotumor\\ cerebri\\ \\(idiopathic\\ intracranial\\ hypertension\\)\\ was\\ made\\.\ \(0\)\
\-\ pseudotumor\\ cerebri\\,\\ while\\ labeled\\ idiopathic\\,\\ has\\ been\\ known\\ to\\ be\\ associated\\ with\\ a\\ number\\ of\\ medications\\,\\ one\\ of\\ which\\ is\\ corticosteroids\\.\\ furthermore\\,\\ the\\ epidemiology\\ of\\ pseudotumor\\ cerebri\\ shows\\ the\\ incidence\\ favors\\ females\\ to\\ males\\ in\\ a\\ 9\\:1\\ ratio\\.\\ it\\ usually\\ affects\\ patients\\ in\\ the\\ 3rd\\ decade\\ of\\ life\\,\\ and\\ is\\ correlated\\ with\\ being\\ overweight\\ or\\ obese\\.\\ our\\ patient\\ had\\ all\\ these\\ risk\\ factors\\.\\ the\\ main\\ factor\\ that\\ could\\ be\\ addressed\\ at\\ the\\ time\\ was\\ her\\ obesity\\,\\ and\\ she\\ was\\ appropriately\\ advised\\ on\\ reducing\\ her\\ weight\\.\\ fortunately\\ her\\ papilledema\\ appears\\ to\\ be\\ resolving\\ with\\ lumbar\\ puncture\\ and\\ azetazolamide\\ therapy\\.\ \(0\)\
\-\ this\\ case\\ is\\ a\\ reminder\\ to\\ the\\ primary\\ care\\ practitioners\\ particulary\\,\\ as\\ well\\ as\\ specialists\\ on\\ the\\ case\\,\\ that\\ ih\\ can\\ develop\\ over\\ months\\ or\\ years\\ manifesting\\ as\\ papilledema\\.\\ \\ it\\ is\\ critical\\ then\\ to\\ continue\\ to\\ monitor\\ periodically\\ the\\ fundoscopic\\ appearance\\.\\ \\ in\\ this\\ case\\ the\\ fundoscopic\\ images\\ came\\ from\\ the\\ office\\ of\\ the\\ opthamolgist\\.\\ \\ however\\,\\ this\\ case\\ has\\ resulted\\ in\\ positive\\ change\\ in\\ the\\ office\\ of\\ the\\ doctor\\ of\\ chiropractic\\ to\\ procure\\ better\\ opthamologic\\ equipment\\ and\\ a\\ means\\ for\\ recording\\ optic\\ disc\\ pictures\\ for\\ documentation\\ and\\ possible\\ comparative\\ evaluation\\ over\\ time\\.\\ \\ \\ \\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ digre\\ kb\\ et\\ al\\.\\ \\ \\"a\\ comparison\\ of\\ idiopathic\\ intracranial\\ hypertension\\ with\\ and\\ without\\ papilledema\\"\\.\\ \\ headache\\.\\ 2009\\ february\\ \\;\\ 49\\(2\\)\\:\\ 185\\‚\\Ä\\ì193\\.\ \(0\)\
\-\ headache\\ classification\\ subcommittee\\ of\\ the\\ international\\ headache\\ society\\.\\ the\\ international\\ classification\\ of\\ headache\\ disorders\\.\\ cephalagia\\.\\ 2004\\;\\ 24\\(suppl\\ 1\\)\\:8\\‚\\Ä\\ì160\\.\ \(0\)\
\-\ intracranial\\ hypertension\\ research\\ foundation\\"\\ \\"acute\\ ih\\ vs\\.\\ chronic\\ ih\\.\\"\\ http\\:\\/\\/ihrfoundation\\.org\\/hypertension\\/info\\/c62\\/\ \(0\)\
\-\ kesler\\ a\\,\\ md1\\,\\ mosek\\ a\\,\\ fithlicher\\ n\\,\\ gidron\\ y\\.\\ \\ \\"psychological\\ correlates\\ of\\ idiopathic\\ intracranial\\ hypertension\\"\\.\\ \\ imaj\\.\\ \\ 2005\\;\\ 7\\:\\ 627\\-630\\.\ \(0\)\
\-\ catz\\ a\\.\\,\\ appel\\ i\\,\\ reider\\-grosswasser\\ i\\,\\ grosswasser\\ z\\,\\ mendelson\\ l\\,\\ gepstein\\ r\\.\\ \\ \\"late\\-onset\\ papilledema\\ following\\ spinal\\ injury\\.\\ case\\ report\\"\\.\\ \\ paraplegia\\ \\(1993\\)\\ 31\\,\\ 131\\‚\\Ä\\ì135\\;\\ doi\\:10\\.1038\\/sc\\.1993\\.24\ \(0\)\
\-\ mathews\\ mk\\,\\ sergott\\ rc\\,\\ savino\\ pj\\.\\ \\"pseudotumor\\ cerebri\\.\\"\\ curr\\ opin\\ ophthalmol\\.\\ dec\\ 2003\\;14\\(6\\)\\:364\\-70\\.\ \(0\)\
\-\ gans\\ ms\\.\\ \\"idiopathic\\ intracranial\\ hypertension\\.\\"\\ medscape\\ reference\\.\\ http\\:\\/\\/emedicine\\.medscape\\.com\\/article\\/1214410\\-overview\\.\\ updated\\:\\ may\\ 2\\,\\ 2014\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ papilledema\\:\\ 0\\.03767258958263082\ \(0\)\
\-\ mva\\:\\ 0\\.03154325298987203\ \(0\)\
\-\ she\\:\\ 0\\.027507159800823563\ \(0\)\
\-\ iih\\:\\ 0\\.027394169454996804\ \(0\)\
\-\ her\\:\\ 0\\.024264258494967352\ \(0\)\
\-\ qd\\:\\ 0\\.017112034179617864\ \(0\)\
\-\ foraminal\\:\\ 0\\.01696906843186589\ \(0\)\
\-\ ih\\:\\ 0\\.014865966988139119\ \(0\)\
\-\ disc\\:\\ 0\\.014762766167677984\ \(0\)\
\-\ following\\:\\ 0\\.013905471118826146\ \(0\)\
\-\ tab\\:\\ 0\\.013697084727498402\ \(0\)\
\-\ \\;\\:\\ 0\\.013662200259376684\ \(0\)\
\-\ intracranial\\:\\ 0\\.013398525836690297\ \(0\)\
\-\ cerebri\\:\\ 0\\.013309359917480562\ \(0\)\
\-\ was\\:\\ 0\\.012999265890837702\ \(0\)\
\-\ months\\:\\ 0\\.012594624187197666\ \(0\)\
\-\ cervical\\:\\ 0\\.012566980397672695\ \(0\)\
\-\ neuropsychiatrist\\:\\ 0\\.011892773590511297\ \(0\)\
\-\ pseudotumor\\:\\ 0\\.01167292475258356\ \(0\)\
\-\ pressure\\:\\ 0\\.011318492107326607\ \(0\)\
\-\ puncture\\:\\ 0\\.010644526871791737\ \(0\)\
\-\ intervertebral\\:\\ 0\\.010644526871791737\ \(0\)\
\-\ fundoscopic\\:\\ 0\\.01054058864503366\ \(0\)\
\-\ \\,\\:\\ 0\\.010499715863233743\ \(0\)\
\-\ tap\\:\\ 0\\.010415617359782865\ \(0\)\
\-\ spinal\\:\\ 0\\.010319649950690003\ \(0\)\
\-\ \\:\\:\\ 0\\.010292553130437759\ \(0\)\
\-\ then\\:\\ 0\\.0102562120688772\ \(0\)\
\-\ hypertension\\:\\ 0\\.0102256423172687\ \(0\)\
\-\ stenosis\\:\\ 0\\.010160918902354907\ \(0\)\
\-\ neurologist\\:\\ 0\\.010088204181973493\ \(0\)\
\-\ md\\:\\ 0\\.009963841489653747\ \(0\)\
\-\ reported\\:\\ 0\\.009455539175440912\ \(0\)\
\-\ idiopathic\\:\\ 0\\.009196884481271034\ \(0\)\
\-\ as\\:\\ 0\\.009154849114258578\ \(0\)\
\-\ such\\:\\ 0\\.009009554097271001\ \(0\)\
\-\ ptsd\\:\\ 0\\.008919580192883471\ \(0\)\
\-\ azetazolamide\\:\\ 0\\.008919580192883471\ \(0\)\
\-\ catz\\:\\ 0\\.008919580192883471\ \(0\)\
\-\ headache\\:\\ 0\\.008908893402391966\ \(0\)\
\-\ lumbar\\:\\ 0\\.008578800713565225\ \(0\)\
\-\ to\\:\\ 0\\.008498151230400063\ \(0\)\
\-\ neck\\:\\ 0\\.008462877359252892\ \(0\)\
\-\ increased\\:\\ 0\\.00846064667170181\ \(0\)\
\-\ evaluation\\:\\ 0\\.00837180032319328\ \(0\)\
\-\ pathology\\:\\ 0\\.00825692715374569\ \(0\)\
\-\ 1\\:\\ 0\\.008229314136767784\ \(0\)\
\-\ bending\\:\\ 0\\.008048005322313572\ \(0\)\
\-\ canal\\:\\ 0\\.008015137933510788\ \(0\)\
\-\ chiropractic\\:\\ 0\\.007906212544555492\ \(0\)\
\-\ mg\\:\\ 0\\.007906212544555492\ \(0\)\
\-\ ophthalmic\\:\\ 0\\.007851313525008442\ \(0\)\
\-\ medications\\:\\ 0\\.007713130761594008\ \(0\)\
\-\ dc\\:\\ 0\\.0076307908647860155\ \(0\)\
\-\ evidence\\:\\ 0\\.007556298763463331\ \(0\)\
\-\ 5mg\\:\\ 0\\.007516921480114611\ \(0\)\
\-\ 18\\:\\ 0\\.007506724350892244\ \(0\)\
\-\ is\\:\\ 0\\.007396067574031805\ \(0\)\
\-\ cap\\:\\ 0\\.007350047344323809\ \(0\)\
\-\ office\\:\\ 0\\.007304311692822047\ \(0\)\
\-\ publication\\:\\ 0\\.007291143856525191\ \(0\)\
\-\ algometry\\:\\ 0\\.007291143856525191\ \(0\)\
\-\ disability\\:\\ 0\\.007175731349072537\ \(0\)\
\-\ scored\\:\\ 0\\.007106670105974815\ \(0\)\
\-\ or\\:\\ 0\\.007093415759945315\ \(0\)\
\-\ significant\\:\\ 0\\.006974915466943679\ \(0\)\
\-\ migraines\\:\\ 0\\.006950699772254149\ \(0\)\
\-\ case\\:\\ 0\\.0069357668672984756\ \(0\)\
\-\ for\\:\\ 0\\.006885338334568642\ \(0\)\
\-\ 2\\:\\ 0\\.006826694590764253\ \(0\)\
\-\ questionnaire\\:\\ 0\\.00681559212373018\ \(0\)\
\-\ the\\:\\ 0\\.0067609262333982265\ \(0\)\
\-\ optic\\:\\ 0\\.006670667823954175\ \(0\)\
\-\ vision\\:\\ 0\\.0066576458237958104\ \(0\)\
\-\ central\\:\\ 0\\.0066379155136660085\ \(0\)\
\-\ evident\\:\\ 0\\.006594002774920857\ \(0\)\
\-\ classification\\:\\ 0\\.006588455704879827\ \(0\)\
\-\ chronic\\:\\ 0\\.006494407103964924\ \(0\)\
\-\ \\‚\\Ä\\ì\\:\\ 0\\.006485168843828832\ \(0\)\
\-\ performed\\:\\ 0\\.006428541871776915\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.006252190731143401\ \(0\)\
\-\ international\\:\\ 0\\.0060529225091840964\ \(0\)\
\-\ being\\:\\ 0\\.006025877861991011\ \(0\)\
\-\ diagnosis\\:\\ 0\\.005956146366618475\ \(0\)\
\-\ 40o\\/80o\\:\\ 0\\.005946386795255648\ \(0\)\
\-\ frisen\\:\\ 0\\.005946386795255648\ \(0\)\
\-\ zanaflex\\:\\ 0\\.005946386795255648\ \(0\)\
\-\ tabs\\:\\ 0\\.005946386795255648\ \(0\)\
\-\ blurriness\\:\\ 0\\.005946386795255648\ \(0\)\
\-\ digre\\:\\ 0\\.005946386795255648\ \(0\)\
\-\ opthamolgist\\:\\ 0\\.005946386795255648\ \(0\)\
\-\ does\\:\\ 0\\.005900076365026656\ \(0\)\
\-\ reports\\:\\ 0\\.005809241814230751\ \(0\)\
\-\ no\\:\\ 0\\.005804007761914347\ \(0\)\
\-\ tested\\:\\ 0\\.005747073397676912\ \(0\)\
\-\ anxiety\\:\\ 0\\.005662707520166911\ \(0\)\
\-\ had\\:\\ 0\\.0055968459943225544\ \(0\)\
\-\ injury\\:\\ 0\\.005512732293872782\ \(0\)\
\-\ our\\:\\ 0\\.005479835727298663\ \(0\)\
\-\ 25o\\/45o\\:\\ 0\\.005478833890999361\ \(0\)\
\-\ neurontin\\:\\ 0\\.005478833890999361\ \(0\)\
\-\ 300mg\\:\\ 0\\.005478833890999361\ \(0\)\
\-\ caps\\:\\ 0\\.005478833890999361\ \(0\)\
\-\ celexa\\:\\ 0\\.005478833890999361\ \(0\)\
\-\ drive\\:\\ 0\\.005478833890999361\ \(0\)\
\-\ a\\:\\ 0\\.005350418911549426\ \(0\)\
\-\ flexion\\:\\ 0\\.00530551973204739\ \(0\)\
\-\ pain\\:\\ 0\\.005279636597963245\ \(0\)\
\-\ shoulders\\:\\ 0\\.005239054567527938\ \(0\)\
\-\ doctor\\:\\ 0\\.005239054567527938\ \(0\)\
\-\ oswestry\\:\\ 0\\.0052053329749061645\ \(0\)\
\-\ 1mg\\:\\ 0\\.0052053329749061645\ \(0\)\
\-\ ssd\\:\\ 0\\.0052053329749061645\ \(0\)\
\-\ there\\:\\ 0\\.005146909503399616\ \(0\)\
\-\ extension\\:\\ 0\\.005143890929480022\ \(0\)\
\-\ 40mg\\:\\ 0\\.005011280986743074\ \(0\)\
\-\ lbs\\:\\ 0\\.0049818193516248275\ \(0\)\
\-\ another\\:\\ 0\\.004956296617151889\ \(0\)\
\-\ stage\\:\\ 0\\.004917415755721209\ \(0\)\
\-\ validity\\:\\ 0\\.004860762571016795\ \(0\)\
\-\ overdose\\:\\ 0\\.004860762571016795\ \(0\)\
\-\ without\\:\\ 0\\.0047501154011828405\ \(0\)\
\-\ spine\\:\\ 0\\.004745537177074786\ \(0\)\
\-\ 2004\\:\\ 0\\.004650263796415235\ \(0\)\
\-\ range\\:\\ 0\\.004641133242876672\ \(0\)\
\-\ motion\\:\\ 0\\.0046349019499845375\ \(0\)\
\-\ 10mg\\:\\ 0\\.004633799848169433\ \(0\)\
\-\ herself\\:\\ 0\\.004633799848169433\ \(0\)\
\-\ icp\\:\\ 0\\.004543728082486788\ \(0\)\
\-\ left\\:\\ 0\\.0045144936829075236\ \(0\)\
\-\ that\\:\\ 0\\.004480211317716496\ \(0\)\
\-\ approximately\\:\\ 0\\.004458377447817172\ \(0\)\
\-\ be\\:\\ 0\\.004444373434549508\ \(0\)\
\-\ cns\\:\\ 0\\.004424486172825815\ \(0\)\
\-\ during\\:\\ 0\\.004409796374239137\ \(0\)\
\-\ prescription\\:\\ 0\\.004393209666760507\ \(0\)\
\-\ referred\\:\\ 0\\.004350126736533749\ \(0\)\
\-\ uncovertebral\\:\\ 0\\.004328919494885753\ \(0\)\
\-\ prn\\:\\ 0\\.004328919494885753\ \(0\)\
\-\ evaluations\\:\\ 0\\.004328919494885753\ \(0\)\
\-\ month\\:\\ 0\\.004323127387522107\ \(0\)\
\-\ by\\:\\ 0\\.004319001055380732\ \(0\)\
\-\ conditions\\:\\ 0\\.004301352680437094\ \(0\)\
\-\ sided\\:\\ 0\\.004262430506774564\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.004249851678175684\ \(0\)\
\-\ diagnosed\\:\\ 0\\.004239049115406415\ \(0\)\
\-\ asymmetric\\:\\ 0\\.00420109207067902\ \(0\)\
\-\ upper\\:\\ 0\\.004172844192988974\ \(0\)\
\-\ specialist\\:\\ 0\\.004166246943913147\ \(0\)\
\-\ did\\:\\ 0\\.004162453478573928\ \(0\)\
\-\ rotation\\:\\ 0\\.004154456886327991\ \(0\)\
\-\ \\(\\:\\ 0\\.004141702983522978\ \(0\)\
\-\ changes\\:\\ 0\\.004129929133617302\ \(0\)\
\-\ society\\:\\ 0\\.00411970875066731\ \(0\)\
\-\ fit\\:\\ 0\\.00411970875066731\ \(0\)\
\-\ \\)\\:\\ 0\\.004091109870464144\ \(0\)\
\-\ 1\\/4\\:\\ 0\\.0040761751782305\ \(0\)\
\-\ vehicle\\:\\ 0\\.004026208954821268\ \(0\)\
\-\ having\\:\\ 0\\.003971503503283047\ \(0\)\
\-\ contribute\\:\\ 0\\.003925656762504221\ \(0\)\
\-\ j\\:\\ 0\\.003905252647249818\ \(0\)\
\-\ discs\\:\\ 0\\.0038927460278199493\ \(0\)\
\-\ and\\:\\ 0\\.0038855232265976327\ \(0\)\
\-\ disorder\\:\\ 0\\.0038840991718845767\ \(0\)\
\-\ possible\\:\\ 0\\.00388260670338492\ \(0\)\
\-\ report\\:\\ 0\\.0038702386211006017\ \(0\)\
\-\ within\\:\\ 0\\.0038485395813499398\ \(0\)\
\-\ from\\:\\ 0\\.00384415562171599\ \(0\)\
\-\ swelling\\:\\ 0\\.003840554285303383\ \(0\)\
\-\ going\\:\\ 0\\.0038026742621373034\ \(0\)\
\-\ exam\\:\\ 0\\.003798787062292488\ \(0\)\
\-\ chiropractor\\:\\ 0\\.003775138346777941\ \(0\)\
\-\ development\\:\\ 0\\.0037657014062324476\ \(0\)\
\-\ c5\\-6\\:\\ 0\\.0037486825537571774\ \(0\)\
\-\ orbits\\:\\ 0\\.0037486825537571774\ \(0\)\
\-\ have\\:\\ 0\\.0037445627218180605\ \(0\)\
\-\ graded\\:\\ 0\\.0036986940396568596\ \(0\)\
\-\ over\\:\\ 0\\.003668874519628942\ \(0\)\
\-\ al\\:\\ 0\\.0036653236827078797\ \(0\)\
\-\ advised\\:\\ 0\\.003630037922078484\ \(0\)\
\-\ csf\\:\\ 0\\.003610618231169658\ \(0\)\
\-\ obesity\\:\\ 0\\.0036086222739742132\ \(0\)\
\-\ maintained\\:\\ 0\\.0036086222739742132\ \(0\)\
\-\ an\\:\\ 0\\.0035868410720278476\ \(0\)\
\-\ after\\:\\ 0\\.0035777427371518427\ \(0\)\
\-\ related\\:\\ 0\\.0035688884248957463\ \(0\)\
\-\ opening\\:\\ 0\\.003567728768533111\ \(0\)\
\-\ this\\:\\ 0\\.0035657704372531076\ \(0\)\
\-\ hand\\:\\ 0\\.0035536730346449464\ \(0\)\
\-\ et\\:\\ 0\\.00353868306589101\ \(0\)\
\-\ corticosteroids\\:\\ 0\\.003510691744568144\ \(0\)\
\-\ brain\\:\\ 0\\.003468939660442175\ \(0\)\
\-\ patient\\:\\ 0\\.0034668138856649763\ \(0\)\
\-\ documented\\:\\ 0\\.003458103858247934\ \(0\)\
\-\ sagittal\\:\\ 0\\.0034485800868529976\ \(0\)\
\-\ made\\:\\ 0\\.003444052990331998\ \(0\)\
\-\ emg\\:\\ 0\\.0034414477957923715\ \(0\)\
\-\ directed\\:\\ 0\\.0034414477957923715\ \(0\)\
\-\ on\\:\\ 0\\.003418035134271836\ \(0\)\
\-\ noted\\:\\ 0\\.003415550064844171\ \(0\)\
\-\ extremities\\:\\ 0\\.0033912512164663284\ \(0\)\
\-\ 3\\:\\ 0\\.0033743263519503196\ \(0\)\
\-\ depression\\:\\ 0\\.003363829360861655\ \(0\)\
\-\ index\\:\\ 0\\.0033493226457041755\ \(0\)\
\-\ right\\:\\ 0\\.0033450080270538227\ \(0\)\
\-\ not\\:\\ 0\\.003331719856302018\ \(0\)\
\-\ vertebrae\\:\\ 0\\.0033212129010832185\ \(0\)\
\-\ 7\\:\\ 0\\.0033129054423015904\ \(0\)\
\-\ headaches\\:\\ 0\\.0033050006803419336\ \(0\)\
\-\ active\\:\\ 0\\.0033010713379880746\ \(0\)\
\-\ were\\:\\ 0\\.0032719837043674893\ \(0\)\
\-\ can\\:\\ 0\\.0032685031238938777\ \(0\)\
\-\ time\\:\\ 0\\.0032561230721609613\ \(0\)\
\-\ resulted\\:\\ 0\\.0032556724299509098\ \(0\)\
\-\ has\\:\\ 0\\.0032472849318602587\ \(0\)\
\-\ occur\\:\\ 0\\.003243892035866649\ \(0\)\
\-\ itself\\:\\ 0\\.0032432952706468988\ \(0\)\
\-\ studies\\:\\ 0\\.003229174621698981\ \(0\)\
\-\ of\\:\\ 0\\.0032220275431484153\ \(0\)\
\-\ 4\\:\\ 0\\.00321210375066313\ \(0\)\
\-\ however\\:\\ 0\\.0032099400412776667\ \(0\)\
\-\ since\\:\\ 0\\.003175815806102748\ \(0\)\
\-\ correlation\\:\\ 0\\.0031734533286969222\ \(0\)\
\-\ may\\:\\ 0\\.003160756102694981\ \(0\)\
\-\ trauma\\:\\ 0\\.0031527943092855702\ \(0\)\
\-\ criteria\\:\\ 0\\.003151692207470466\ \(0\)\
\-\ been\\:\\ 0\\.003136316882919381\ \(0\)\
\-\ one\\:\\ 0\\.0031240895558996887\ \(0\)\
\-\ later\\:\\ 0\\.0031218401089304453\ \(0\)\
\-\ care\\:\\ 0\\.0031185603511656853\ \(0\)\
\-\ lateral\\:\\ 0\\.0031141113754208265\ \(0\)\
\-\ weight\\:\\ 0\\.003099101974847418\ \(0\)\
\-\ facet\\:\\ 0\\.00306162044178782\ \(0\)\
\-\ 138\\/86mmhg\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ 40o\\/50o\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ 25o\\/60o\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ fairbanks\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ davies\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ physiother\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ \\:271\\-273\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ manpipulative\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ 14\\:409\\-415\\.\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ mccreary\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ 64\\:560\\-563\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ 30\\:115\\-26\\.\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ 40cmh2o\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ 25cmh2o\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ 19cmh2o\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ infection\\/inflammatory\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ licensed\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ ibs\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ klonopin\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ predisone\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ seroquel\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ abilify\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ 75mg\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ vynase\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ pro\\-air\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ 15mg\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ klonipin\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ linzess\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ 145mcg\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ bentyl\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ protonix\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ detrol\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ rheumatolgoist\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ acted\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ electrodiagnositic\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ physiatric\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ 1x\\/month\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ giodon\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ ophthamologist\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ opthamologist\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ doan\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ enumerated\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ iihwop\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ underscore\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ opthalmoscopic\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ iicp\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ contraindicate\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ flareup\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ 9\\:1\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ procure\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ opthamologic\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ kb\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ 185\\‚\\Ä\\ì193\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ subcommittee\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ cephalagia\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ \\:8\\‚\\Ä\\ì160\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ \\/\\/ihrfoundation\\.org\\/hypertension\\/info\\/c62\\/\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ kesler\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ md1\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ mosek\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ fithlicher\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ gidron\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ imaj\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ 627\\-630\\.\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ reider\\-grosswasser\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ grosswasser\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ mendelson\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ gepstein\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ 131\\‚\\Ä\\ì135\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ doi\\:10\\.1038\\/sc\\.1993\\.24\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ mathews\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ sergott\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ savino\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ opin\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ \\:364\\-70\\.\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ gans\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ \\/\\/emedicine\\.medscape\\.com\\/article\\/1214410\\-overview\\:\\ 0\\.002973193397627824\ \(0\)\
\-\ prior\\:\\ 0\\.0029600172306271347\ \(0\)\
\-\ sent\\:\\ 0\\.002933969851812421\ \(0\)\
\-\ cause\\:\\ 0\\.002925392202244822\ \(0\)\
\-\ extending\\:\\ 0\\.002906629729011599\ \(0\)\
\-\ medication\\:\\ 0\\.00290364851092725\ \(0\)\
\-\ discomfort\\:\\ 0\\.0028889841017289996\ \(0\)\
\-\ unremarkable\\:\\ 0\\.0028624618064236698\ \(0\)\
\-\ back\\:\\ 0\\.002852343678260516\ \(0\)\
\-\ acute\\:\\ 0\\.0028463802079008367\ \(0\)\
\-\ study\\:\\ 0\\.0028448209344282887\ \(0\)\
\-\ bilaterally\\:\\ 0\\.0028398366662973724\ \(0\)\
\-\ denied\\:\\ 0\\.0028071218035810963\ \(0\)\
\-\ testing\\:\\ 0\\.0027881195256946227\ \(0\)\
\-\ revealed\\:\\ 0\\.002774847106103973\ \(0\)\
\-\ disorders\\:\\ 0\\.002757592313830798\ \(0\)\
\-\ 330\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ physiol\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ left\\/right\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ reproducibility\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ 250mg\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ i\\-\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ stereo\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ lexapro\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ 30mg\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ retroorbital\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ geodon\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ 60mg\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ \\¬\\Ω\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ q8h\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ 4mg\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ imuran\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ prolotherapy\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ counselor\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ christopher\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ demostrate\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ triggered\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ latency\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ reminder\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ practitioners\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ manifesting\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ pictures\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ appel\\:\\ 0\\.0027394169454996804\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.0027226947257031828\ \(0\)\
\-\ repeat\\:\\ 0\\.002711452194515856\ \(0\)\
\-\ degree\\:\\ 0\\.002700393975442887\ \(0\)\
\-\ in\\:\\ 0\\.0027003532454181597\ \(0\)\
\-\ which\\:\\ 0\\.0026899571454343145\ \(0\)\
\-\ clinical\\:\\ 0\\.002660347183877913\ \(0\)\
\-\ other\\:\\ 0\\.0026571852259054955\ \(0\)\
\-\ incidence\\:\\ 0\\.0026426162725231616\ \(0\)\
\-\ accident\\:\\ 0\\.002617905221474406\ \(0\)\
\-\ degenerative\\:\\ 0\\.002613069815418006\ \(0\)\
\-\ vernon\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ mior\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ predicting\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ paraspinals\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ fischer\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ acetazolamide\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ oxycontin\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ methocarbamol\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ inhaler\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ sumatriptan\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ deplin\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ levoquin\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ timeline\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ causally\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ kessler\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ served\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ particulary\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ recording\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ psychological\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ late\\-onset\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ mk\\:\\ 0\\.0026026664874530822\ \(0\)\
\-\ it\\:\\ 0\\.0025913637565369535\ \(0\)\
\-\ factors\\:\\ 0\\.0025893994479230516\ \(0\)\
\-\ 6\\:\\ 0\\.002582246369013363\ \(0\)\
\-\ marrow\\:\\ 0\\.0025357656786631974\ \(0\)\
\-\ rehabil\\:\\ 0\\.002505640493371537\ \(0\)\
\-\ closing\\:\\ 0\\.002505640493371537\ \(0\)\
\-\ accentuation\\:\\ 0\\.002505640493371537\ \(0\)\
\-\ t\\-bone\\:\\ 0\\.002505640493371537\ \(0\)\
\-\ 800\\:\\ 0\\.002505640493371537\ \(0\)\
\-\ 100mg\\:\\ 0\\.002505640493371537\ \(0\)\
\-\ 20mg\\:\\ 0\\.002505640493371537\ \(0\)\
\-\ q6h\\:\\ 0\\.002505640493371537\ \(0\)\
\-\ constipated\\:\\ 0\\.002505640493371537\ \(0\)\
\-\ therapist\\:\\ 0\\.002505640493371537\ \(0\)\
\-\ 9\\-10\\:\\ 0\\.002505640493371537\ \(0\)\
\-\ principal\\:\\ 0\\.002505640493371537\ \(0\)\
\-\ pj\\:\\ 0\\.002505640493371537\ \(0\)\
\-\ curr\\:\\ 0\\.002505640493371537\ \(0\)\
\-\ ophthalmol\\:\\ 0\\.002505640493371537\ \(0\)\
\-\ causing\\:\\ 0\\.0024900873150510887\ \(0\)\
\-\ focal\\:\\ 0\\.0024693021289764606\ \(0\)\
\-\ arthritis\\:\\ 0\\.0024625513996917262\ \(0\)\
\-\ 1980\\:\\ 0\\.0024303812855083974\ \(0\)\
\-\ robinson\\:\\ 0\\.0024303812855083974\ \(0\)\
\-\ hyperalgesia\\:\\ 0\\.0024303812855083974\ \(0\)\
\-\ bipolar\\:\\ 0\\.0024303812855083974\ \(0\)\
\-\ oxycodone\\:\\ 0\\.0024303812855083974\ \(0\)\
\-\ obgyn\\:\\ 0\\.0024303812855083974\ \(0\)\
\-\ massage\\:\\ 0\\.0024303812855083974\ \(0\)\
\-\ applying\\:\\ 0\\.0024303812855083974\ \(0\)\
\-\ specialists\\:\\ 0\\.0024303812855083974\ \(0\)\
\-\ equipment\\:\\ 0\\.0024303812855083974\ \(0\)\
\-\ suppl\\:\\ 0\\.0024303812855083974\ \(0\)\
\-\ foundation\\:\\ 0\\.0024303812855083974\ \(0\)\
\-\ rc\\:\\ 0\\.0024303812855083974\ \(0\)\
\-\ secondary\\:\\ 0\\.0024172309947812554\ \(0\)\
\-\ condition\\:\\ 0\\.002410638387120982\ \(0\)\
\-\ low\\:\\ 0\\.002404217254164991\ \(0\)\
\-\ i\\:\\ 0\\.002382674330676904\ \(0\)\
\-\ limits\\:\\ 0\\.0023758607752054003\ \(0\)\
\-\ indices\\:\\ 0\\.0023688900353249385\ \(0\)\
\-\ 1983\\:\\ 0\\.0023688900353249385\ \(0\)\
\-\ photographs\\:\\ 0\\.0023688900353249385\ \(0\)\
\-\ nurse\\:\\ 0\\.0023688900353249385\ \(0\)\
\-\ fibromyalgia\\:\\ 0\\.0023688900353249385\ \(0\)\
\-\ tramadol\\:\\ 0\\.0023688900353249385\ \(0\)\
\-\ post\\-mva\\:\\ 0\\.0023688900353249385\ \(0\)\
\-\ subsided\\:\\ 0\\.0023688900353249385\ \(0\)\
\-\ understand\\:\\ 0\\.0023688900353249385\ \(0\)\
\-\ overt\\:\\ 0\\.0023688900353249385\ \(0\)\
\-\ where\\:\\ 0\\.002352541150203654\ \(0\)\
\-\ lesion\\:\\ 0\\.002348135212142266\ \(0\)\
\-\ initially\\:\\ 0\\.002346023840988317\ \(0\)\
\-\ treatment\\:\\ 0\\.002333378697606593\ \(0\)\
\-\ results\\:\\ 0\\.0023268414225596267\ \(0\)\
\-\ shoulder\\:\\ 0\\.0023236967256923006\ \(0\)\
\-\ revised\\:\\ 0\\.0023168999240847166\ \(0\)\
\-\ computerized\\:\\ 0\\.0023168999240847166\ \(0\)\
\-\ levator\\:\\ 0\\.0023168999240847166\ \(0\)\
\-\ counseled\\:\\ 0\\.0023168999240847166\ \(0\)\
\-\ c2\\-3\\:\\ 0\\.0023168999240847166\ \(0\)\
\-\ tid\\:\\ 0\\.0023168999240847166\ \(0\)\
\-\ dosage\\:\\ 0\\.0023168999240847166\ \(0\)\
\-\ concept\\:\\ 0\\.0023168999240847166\ \(0\)\
\-\ latent\\:\\ 0\\.0023168999240847166\ \(0\)\
\-\ complicate\\:\\ 0\\.0023168999240847166\ \(0\)\
\-\ z\\:\\ 0\\.0023168999240847166\ \(0\)\
\-\ vertebral\\:\\ 0\\.002281144297074036\ \(0\)\
\-\ ther\\:\\ 0\\.002271864041243394\ \(0\)\
\-\ obscuration\\:\\ 0\\.002271864041243394\ \(0\)\
\-\ hospitalizations\\:\\ 0\\.002271864041243394\ \(0\)\
\-\ pushing\\:\\ 0\\.002271864041243394\ \(0\)\
\-\ approaching\\:\\ 0\\.002271864041243394\ \(0\)\
\-\ imperative\\:\\ 0\\.002271864041243394\ \(0\)\
\-\ periodically\\:\\ 0\\.002271864041243394\ \(0\)\
\-\ comparative\\:\\ 0\\.002271864041243394\ \(0\)\
\-\ paraplegia\\:\\ 0\\.002271864041243394\ \(0\)\
\-\ medscape\\:\\ 0\\.002271864041243394\ \(0\)\
\-\ minimal\\:\\ 0\\.0022694637237104876\ \(0\)\
\-\ normal\\:\\ 0\\.0022590429251249594\ \(0\)\
\-\ these\\:\\ 0\\.002250095809738118\ \(0\)\
\-\ 24\\:\\ 0\\.002241117693508229\ \(0\)\
\-\ threshold\\:\\ 0\\.00223213957727834\ \(0\)\
\-\ 1987\\:\\ 0\\.00223213957727834\ \(0\)\
\-\ controlling\\:\\ 0\\.00223213957727834\ \(0\)\
\-\ c7\\-t1\\:\\ 0\\.00223213957727834\ \(0\)\
\-\ motrin\\:\\ 0\\.00223213957727834\ \(0\)\
\-\ frame\\:\\ 0\\.00223213957727834\ \(0\)\
\-\ overweight\\:\\ 0\\.00223213957727834\ \(0\)\
\-\ fortunately\\:\\ 0\\.00223213957727834\ \(0\)\
\-\ documentation\\:\\ 0\\.00223213957727834\ \(0\)\
\-\ about\\:\\ 0\\.0022219612182828004\ \(0\)\
\-\ second\\:\\ 0\\.0022139149647480458\ \(0\)\
\-\ tightness\\:\\ 0\\.0021966048333802537\ \(0\)\
\-\ reliability\\:\\ 0\\.0021966048333802537\ \(0\)\
\-\ phys\\:\\ 0\\.0021966048333802537\ \(0\)\
\-\ addressed\\:\\ 0\\.0021966048333802537\ \(0\)\
\-\ 50\\:\\ 0\\.0021929160314629373\ \(0\)\
\-\ http\\:\\ 0\\.00218265672713678\ \(0\)\
\-\ management\\:\\ 0\\.0021750633682668745\ \(0\)\
\-\ confirmed\\:\\ 0\\.0021675545383384805\ \(0\)\
\-\ ja\\:\\ 0\\.0021644597474428763\ \(0\)\
\-\ bifrontal\\:\\ 0\\.0021644597474428763\ \(0\)\
\-\ dandy\\:\\ 0\\.0021644597474428763\ \(0\)\
\-\ action\\:\\ 0\\.0021644597474428763\ \(0\)\
\-\ turner\\:\\ 0\\.0021351135831967952\ \(0\)\
\-\ nonsurgical\\:\\ 0\\.0021351135831967952\ \(0\)\
\-\ craniocervical\\:\\ 0\\.0021351135831967952\ \(0\)\
\-\ exit\\:\\ 0\\.0021351135831967952\ \(0\)\
\-\ morphine\\:\\ 0\\.0021351135831967952\ \(0\)\
\-\ xr\\:\\ 0\\.0021351135831967952\ \(0\)\
\-\ urologist\\:\\ 0\\.0021351135831967952\ \(0\)\
\-\ could\\:\\ 0\\.002126514633275246\ \(0\)\
\-\ cp\\:\\ 0\\.002108117729006732\ \(0\)\
\-\ bid\\:\\ 0\\.002108117729006732\ \(0\)\
\-\ practical\\:\\ 0\\.002108117729006732\ \(0\)\
\-\ blurry\\:\\ 0\\.002108117729006732\ \(0\)\
\-\ cerebrospinal\\:\\ 0\\.002108117729006732\ \(0\)\
\-\ psychiatric\\:\\ 0\\.002108117729006732\ \(0\)\
\-\ favors\\:\\ 0\\.002108117729006732\ \(0\)\
\-\ reducing\\:\\ 0\\.002108117729006732\ \(0\)\
\-\ updated\\:\\ 0\\.002108117729006732\ \(0\)\
\-\ extremity\\:\\ 0\\.0021080330317992833\ \(0\)\
\-\ strengths\\:\\ 0\\.0020831234719565733\ \(0\)\
\-\ motility\\:\\ 0\\.0020831234719565733\ \(0\)\
\-\ 300\\:\\ 0\\.0020831234719565733\ \(0\)\
\-\ detectable\\:\\ 0\\.0020831234719565733\ \(0\)\
\-\ manifests\\:\\ 0\\.0020831234719565733\ \(0\)\
\-\ epidemiology\\:\\ 0\\.0020831234719565733\ \(0\)\
\-\ including\\:\\ 0\\.002081226739286964\ \(0\)\
\-\ required\\:\\ 0\\.0020746883722005155\ \(0\)\
\-\ c4\\-5\\:\\ 0\\.002059854375333655\ \(0\)\
\-\ belt\\:\\ 0\\.002059854375333655\ \(0\)\
\-\ february\\:\\ 0\\.002059854375333655\ \(0\)\
\-\ would\\:\\ 0\\.00205124241377544\ \(0\)\
\-\ weighs\\:\\ 0\\.00203808758911525\ \(0\)\
\-\ bicep\\:\\ 0\\.00203808758911525\ \(0\)\
\-\ helped\\:\\ 0\\.00203808758911525\ \(0\)\
\-\ added\\:\\ 0\\.00203808758911525\ \(0\)\
\-\ closer\\:\\ 0\\.00203808758911525\ \(0\)\
\-\ imaging\\:\\ 0\\.0020257070736481642\ \(0\)\
\-\ \\.\\:\\ 0\\.0020234136932382866\ \(0\)\
\-\ dynamometer\\:\\ 0\\.002017640836394699\ \(0\)\
\-\ c3\\-4\\:\\ 0\\.002017640836394699\ \(0\)\
\-\ belted\\:\\ 0\\.002017640836394699\ \(0\)\
\-\ appointment\\:\\ 0\\.002017640836394699\ \(0\)\
\-\ \\%\\:\\ 0\\.0020168509612269888\ \(0\)\
\-\ ct\\:\\ 0\\.0020156891288230067\ \(0\)\
\-\ tall\\:\\ 0\\.001998363125150197\ \(0\)\
\-\ jamar\\:\\ 0\\.001998363125150197\ \(0\)\
\-\ 1991\\:\\ 0\\.001998363125150197\ \(0\)\
\-\ name\\:\\ 0\\.001998363125150197\ \(0\)\
\-\ labeled\\:\\ 0\\.001998363125150197\ \(0\)\
\-\ correlated\\:\\ 0\\.001998363125150197\ \(0\)\
\-\ side\\:\\ 0\\.0019969285003467595\ \(0\)\
\-\ mri\\:\\ 0\\.0019864511179574565\ \(0\)\
\-\ y\\:\\ 0\\.001980127974637456\ \(0\)\
\-\ 1993\\:\\ 0\\.001980127974637456\ \(0\)\
\-\ 2014\\:\\ 0\\.001980127974637456\ \(0\)\
\-\ limit\\:\\ 0\\.0019628283812521104\ \(0\)\
\-\ neutral\\:\\ 0\\.0019628283812521104\ \(0\)\
\-\ c6\\-7\\:\\ 0\\.0019628283812521104\ \(0\)\
\-\ manner\\:\\ 0\\.0019628283812521104\ \(0\)\
\-\ came\\:\\ 0\\.0019628283812521104\ \(0\)\
\-\ ophthalmology\\:\\ 0\\.0019463730139099747\ \(0\)\
\-\ identifiable\\:\\ 0\\.0019463730139099747\ \(0\)\
\-\ research\\:\\ 0\\.0019463730139099747\ \(0\)\
\-\ recent\\:\\ 0\\.0019377531526743993\ \(0\)\
\-\ pathophysiology\\:\\ 0\\.0019306832953147326\ \(0\)\
\-\ seat\\:\\ 0\\.0019306832953147326\ \(0\)\
\-\ modified\\:\\ 0\\.0019306832953147326\ \(0\)\
\-\ set\\:\\ 0\\.0019306832953147326\ \(0\)\
\-\ width\\:\\ 0\\.001915691132558971\ \(0\)\
\-\ scapula\\:\\ 0\\.0019013371310686517\ \(0\)\
\-\ notes\\:\\ 0\\.0019013371310686517\ \(0\)\
\-\ dec\\:\\ 0\\.0019013371310686517\ \(0\)\
\-\ showed\\:\\ 0\\.0018899178873009758\ \(0\)\
\-\ seated\\:\\ 0\\.0018875691733889705\ \(0\)\
\-\ deltoid\\:\\ 0\\.0018875691733889705\ \(0\)\
\-\ category\\:\\ 0\\.0018875691733889705\ \(0\)\
\-\ correlates\\:\\ 0\\.0018743412768785887\ \(0\)\
\-\ body\\:\\ 0\\.0018720159950685225\ \(0\)\
\-\ joint\\:\\ 0\\.0018640332243116905\ \(0\)\
\-\ c4\\:\\ 0\\.0018616126671035984\ \(0\)\
\-\ read\\:\\ 0\\.0018616126671035984\ \(0\)\
\-\ migraine\\:\\ 0\\.0018616126671035984\ \(0\)\
\-\ passenger\\:\\ 0\\.0018616126671035984\ \(0\)\
\-\ describe\\:\\ 0\\.0018616126671035984\ \(0\)\
\-\ aa\\:\\ 0\\.0018493470198284298\ \(0\)\
\-\ radicular\\:\\ 0\\.0018493470198284298\ \(0\)\
\-\ conduction\\:\\ 0\\.0018493470198284298\ \(0\)\
\-\ permanent\\:\\ 0\\.0018493470198284298\ \(0\)\
\-\ findings\\:\\ 0\\.001840307186296755\ \(0\)\
\-\ 2009\\:\\ 0\\.0018375118360809523\ \(0\)\
\-\ further\\:\\ 0\\.0018330145981789263\ \(0\)\
\-\ pcp\\:\\ 0\\.0018260779232055118\ \(0\)\
\-\ means\\:\\ 0\\.0018260779232055118\ \(0\)\
\-\ found\\:\\ 0\\.001816543416156568\ \(0\)\
\-\ distraction\\:\\ 0\\.001815018961039242\ \(0\)\
\-\ unchanged\\:\\ 0\\.001815018961039242\ \(0\)\
\-\ lieberman\\:\\ 0\\.001815018961039242\ \(0\)\
\-\ while\\:\\ 0\\.0018135913928177493\ \(0\)\
\-\ resolving\\:\\ 0\\.0018043111369871066\ \(0\)\
\-\ occupying\\:\\ 0\\.0017939328372681342\ \(0\)\
\-\ sufficient\\:\\ 0\\.0017939328372681342\ \(0\)\
\-\ appropriately\\:\\ 0\\.0017939328372681342\ \(0\)\
\-\ critical\\:\\ 0\\.0017939328372681342\ \(0\)\
\-\ activities\\:\\ 0\\.0017838643842665554\ \(0\)\
\-\ treating\\:\\ 0\\.0017838643842665554\ \(0\)\
\-\ msiv\\:\\ 0\\.0017838643842665554\ \(0\)\
\-\ jeffrey\\:\\ 0\\.0017740878119652899\ \(0\)\
\-\ accompanied\\:\\ 0\\.0017740878119652899\ \(0\)\
\-\ examinations\\:\\ 0\\.0017740878119652899\ \(0\)\
\-\ days\\:\\ 0\\.0017666605707736779\ \(0\)\
\-\ 2\\/4\\:\\ 0\\.0017645866730220535\ \(0\)\
\-\ extraocular\\:\\ 0\\.0017645866730220535\ \(0\)\
\-\ diet\\:\\ 0\\.0017645866730220535\ \(0\)\
\-\ driver\\:\\ 0\\.0017645866730220535\ \(0\)\
\-\ moving\\:\\ 0\\.0017645866730220535\ \(0\)\
\-\ furthermore\\:\\ 0\\.0017645866730220535\ \(0\)\
\-\ neurology\\:\\ 0\\.001755345872284072\ \(0\)\
\-\ alignment\\:\\ 0\\.001755345872284072\ \(0\)\
\-\ constant\\:\\ 0\\.001755345872284072\ \(0\)\
\-\ consulted\\:\\ 0\\.001755345872284072\ \(0\)\
\-\ describes\\:\\ 0\\.001755345872284072\ \(0\)\
\-\ usually\\:\\ 0\\.0017503731897920804\ \(0\)\
\-\ circumferential\\:\\ 0\\.0017463515225093129\ \(0\)\
\-\ fully\\:\\ 0\\.0017463515225093129\ \(0\)\
\-\ detect\\:\\ 0\\.0017463515225093129\ \(0\)\
\-\ ocular\\:\\ 0\\.0017463515225093129\ \(0\)\
\-\ accomplished\\:\\ 0\\.001729051929123967\ \(0\)\
\-\ fingers\\:\\ 0\\.001729051929123967\ \(0\)\
\-\ induced\\:\\ 0\\.001729051929123967\ \(0\)\
\-\ basis\\:\\ 0\\.001729051929123967\ \(0\)\
\-\ attached\\:\\ 0\\.0017125965617818312\ \(0\)\
\-\ preferred\\:\\ 0\\.0017125965617818312\ \(0\)\
\-\ jennifer\\:\\ 0\\.0017125965617818312\ \(0\)\
\-\ sperrazza\\:\\ 0\\.0017125965617818312\ \(0\)\
\-\ primary\\:\\ 0\\.0017075104640105877\ \(0\)\
\-\ l4\\:\\ 0\\.0017046604749655768\ \(0\)\
\-\ resolve\\:\\ 0\\.0017046604749655768\ \(0\)\
\-\ prednisone\\:\\ 0\\.0017046604749655768\ \(0\)\
\-\ j\\.\\:\\ 0\\.001696906843186589\ \(0\)\
\-\ indicates\\:\\ 0\\.001696906843186589\ \(0\)\
\-\ prescribed\\:\\ 0\\.001696906843186589\ \(0\)\
\-\ receive\\:\\ 0\\.001696906843186589\ \(0\)\
\-\ decade\\:\\ 0\\.001696906843186589\ \(0\)\
\-\ years\\:\\ 0\\.0016925754718505783\ \(0\)\
\-\ s\\.\\:\\ 0\\.0016893274651589136\ \(0\)\
\-\ allergies\\:\\ 0\\.0016893274651589136\ \(0\)\
\-\ picture\\:\\ 0\\.0016893274651589136\ \(0\)\
\-\ 5\\:\\ 0\\.0016864488515643597\ \(0\)\
\-\ triceps\\:\\ 0\\.0016819146804308274\ \(0\)\
\-\ usual\\:\\ 0\\.0016819146804308274\ \(0\)\
\-\ lutnick\\:\\ 0\\.0016819146804308274\ \(0\)\
\-\ clot\\:\\ 0\\.0016819146804308274\ \(0\)\
\-\ effects\\:\\ 0\\.0016819146804308274\ \(0\)\
\-\ gradually\\:\\ 0\\.0016746613228520878\ \(0\)\
\-\ n\\:\\ 0\\.0016746613228520878\ \(0\)\
\-\ you\\:\\ 0\\.0016675606789405084\ \(0\)\
\-\ obese\\:\\ 0\\.0016675606789405084\ \(0\)\
\-\ grip\\:\\ 0\\.0016606064505416092\ \(0\)\
\-\ croce\\:\\ 0\\.0016606064505416092\ \(0\)\
\-\ gary\\:\\ 0\\.0016606064505416092\ \(0\)\
\-\ males\\:\\ 0\\.0016606064505416092\ \(0\)\
\-\ med\\:\\ 0\\.001653792721260827\ \(0\)\
\-\ visit\\:\\ 0\\.001653792721260827\ \(0\)\
\-\ perform\\:\\ 0\\.001653792721260827\ \(0\)\
\-\ iqbal\\:\\ 0\\.001653792721260827\ \(0\)\
\-\ s\\:\\ 0\\.001653131647294831\ \(0\)\
\-\ when\\:\\ 0\\.0016508136510057375\ \(0\)\
\-\ scale\\:\\ 0\\.0016471139262199568\ \(0\)\
\-\ robert\\:\\ 0\\.0016471139262199568\ \(0\)\
\-\ scott\\:\\ 0\\.0016471139262199568\ \(0\)\
\-\ tirone\\:\\ 0\\.0016471139262199568\ \(0\)\
\-\ manifestations\\:\\ 0\\.0016405648247504454\ \(0\)\
\-\ toward\\:\\ 0\\.0016405648247504454\ \(0\)\
\-\ affects\\:\\ 0\\.0016405648247504454\ \(0\)\
\-\ monitor\\:\\ 0\\.0016405648247504454\ \(0\)\
\-\ weeks\\:\\ 0\\.001635937778685429\ \(0\)\
\-\ value\\:\\ 0\\.001634140475687817\ \(0\)\
\-\ produced\\:\\ 0\\.0016278362149754549\ \(0\)\
\-\ exams\\:\\ 0\\.0016278362149754549\ \(0\)\
\-\ charles\\:\\ 0\\.0016278362149754549\ \(0\)\
\-\ vaseem\\:\\ 0\\.0016278362149754549\ \(0\)\
\-\ therapeutic\\:\\ 0\\.0016216476353234494\ \(0\)\
\-\ provide\\:\\ 0\\.0016155705677002863\ \(0\)\
\-\ a\\.\\:\\ 0\\.0016155705677002863\ \(0\)\
\-\ scan\\:\\ 0\\.001613673835030677\ \(0\)\
\-\ occurring\\:\\ 0\\.0016096010644627145\ \(0\)\
\-\ he\\:\\ 0\\.0016082208040694905\ \(0\)\
\-\ subluxation\\:\\ 0\\.0016037353839528092\ \(0\)\
\-\ smith\\:\\ 0\\.0016037353839528092\ \(0\)\
\-\ ruled\\:\\ 0\\.0016037353839528092\ \(0\)\
\-\ females\\:\\ 0\\.0016037353839528092\ \(0\)\
\-\ ratio\\:\\ 0\\.0015979699764117298\ \(0\)\
\-\ 49\\:\\ 0\\.0015979699764117298\ \(0\)\
\-\ combined\\:\\ 0\\.0015923014710773687\ \(0\)\
\-\ history\\:\\ 0\\.0015921949918476673\ \(0\)\
\-\ nearly\\:\\ 0\\.0015867266643484611\ \(0\)\
\-\ example\\:\\ 0\\.0015867266643484611\ \(0\)\
\-\ problem\\:\\ 0\\.001575846103735233\ \(0\)\
\-\ blood\\:\\ 0\\.0015732958330585494\ \(0\)\
\-\ reflex\\:\\ 0\\.0015705346848589633\ \(0\)\
\-\ fields\\:\\ 0\\.0015705346848589633\ \(0\)\
\-\ struck\\:\\ 0\\.0015653056168873055\ \(0\)\
\-\ randall\\:\\ 0\\.0015653056168873055\ \(0\)\
\-\ loftus\\:\\ 0\\.0015653056168873055\ \(0\)\
\-\ radiculopathy\\:\\ 0\\.0015601563851399907\ \(0\)\
\-\ slow\\:\\ 0\\.0015601563851399907\ \(0\)\
\-\ procedures\\:\\ 0\\.0015601563851399907\ \(0\)\
\-\ continue\\:\\ 0\\.0015550845883897243\ \(0\)\
\-\ 2005\\:\\ 0\\.0015550845883897243\ \(0\)\
\-\ 66\\:\\ 0\\.001550087932138412\ \(0\)\
\-\ eyes\\:\\ 0\\.001550087932138412\ \(0\)\
\-\ managed\\:\\ 0\\.001550087932138412\ \(0\)\
\-\ literature\\:\\ 0\\.001550087932138412\ \(0\)\
\-\ reference\\:\\ 0\\.001550087932138412\ \(0\)\
\-\ radiating\\:\\ 0\\.001545164222384229\ \(0\)\
\-\ section\\:\\ 0\\.001545164222384229\ \(0\)\
\-\ impression\\:\\ 0\\.0015403113598371463\ \(0\)\
\-\ contributors\\:\\ 0\\.0015403113598371463\ \(0\)\
\-\ damage\\:\\ 0\\.0015403113598371463\ \(0\)\
\-\ ms\\:\\ 0\\.0015403113598371463\ \(0\)\
\-\ due\\:\\ 0\\.00153812961413345\ \(0\)\
\-\ surgeon\\:\\ 0\\.0015355273345447496\ \(0\)\
\-\ went\\:\\ 0\\.0015355273345447496\ \(0\)\
\-\ every\\:\\ 0\\.00153081022089391\ \(0\)\
\-\ taking\\:\\ 0\\.00153081022089391\ \(0\)\
\-\ 46\\:\\ 0\\.0015261581729572031\ \(0\)\
\-\ finger\\:\\ 0\\.0015261581729572031\ \(0\)\
\-\ krishnan\\:\\ 0\\.0015261581729572031\ \(0\)\
\-\ kartha\\:\\ 0\\.0015261581729572031\ \(0\)\
\-\ behind\\:\\ 0\\.0015215694201559285\ \(0\)\
\-\ h\\:\\ 0\\.0015170422632142288\ \(0\)\
\-\ joanna\\:\\ 0\\.0015125750703811694\ \(0\)\
\-\ garvey\\:\\ 0\\.0015125750703811694\ \(0\)\
\-\ serghany\\:\\ 0\\.0015125750703811694\ \(0\)\
\-\ 31\\:\\ 0\\.0015125750703811694\ \(0\)\
\-\ geoffrey\\:\\ 0\\.0015081662738997688\ \(0\)\
\-\ gerow\\:\\ 0\\.0015081662738997688\ \(0\)\
\-\ who\\:\\ 0\\.0015028454699100857\ \(0\)\
\-\ late\\:\\ 0\\.0014995178993252873\ \(0\)\
\-\ comparison\\:\\ 0\\.0014995178993252873\ \(0\)\
\-\ patients\\:\\ 0\\.001491787250837117\ \(0\)\
\-\ helpful\\:\\ 0\\.0014910857569288565\ \(0\)\
\-\ joseph\\:\\ 0\\.0014910857569288565\ \(0\)\
\-\ better\\:\\ 0\\.0014869474457680422\ \(0\)\
\-\ instability\\:\\ 0\\.0014828592971905228\ \(0\)\
\-\ nonspecific\\:\\ 0\\.0014828592971905228\ \(0\)\
\-\ drug\\:\\ 0\\.0014788201096536877\ \(0\)\
\-\ standard\\:\\ 0\\.001474828724275272\ \(0\)\
\-\ returned\\:\\ 0\\.001474828724275272\ \(0\)\
\-\ dominant\\:\\ 0\\.0014708840228374335\ \(0\)\
\-\ types\\:\\ 0\\.0014708840228374335\ \(0\)\
\-\ factor\\:\\ 0\\.0014708840228374335\ \(0\)\
\-\ end\\:\\ 0\\.0014631303910584456\ \(0\)\
\-\ 2003\\:\\ 0\\.001448138228302684\ \(0\)\
\-\ response\\:\\ 0\\.0014444920508644998\ \(0\)\
\-\ values\\:\\ 0\\.0014408848707239442\ \(0\)\
\-\ help\\:\\ 0\\.0014373158625180296\ \(0\)\
\-\ number\\:\\ 0\\.0014373158625180296\ \(0\)\
\-\ develop\\:\\ 0\\.0014373158625180296\ \(0\)\
\-\ symptoms\\:\\ 0\\.0014365311817188123\ \(0\)\
\-\ characterized\\:\\ 0\\.001433784226812365\ \(0\)\
\-\ progression\\:\\ 0\\.001433784226812365\ \(0\)\
\-\ 34\\:\\ 0\\.001430289189026346\ \(0\)\
\-\ episode\\:\\ 0\\.0014268299984134657\ \(0\)\
\-\ different\\:\\ 0\\.0014268299984134657\ \(0\)\
\-\ 3rd\\:\\ 0\\.0014268299984134657\ \(0\)\
\-\ spaces\\:\\ 0\\.0014200162691326834\ \(0\)\
\-\ expansion\\:\\ 0\\.0014200162691326834\ \(0\)\
\-\ consistent\\:\\ 0\\.0014133546501390916\ \(0\)\
\-\ replacement\\:\\ 0\\.0014067883726223021\ \(0\)\
\-\ color\\:\\ 0\\.0014067883726223021\ \(0\)\
\-\ localized\\:\\ 0\\.0014035609017905481\ \(0\)\
\-\ bilateral\\:\\ 0\\.0013988652474296419\ \(0\)\
\-\ 70\\:\\ 0\\.0013848189621093303\ \(0\)\
\-\ orthopedic\\:\\ 0\\.001375824612334571\ \(0\)\
\-\ followup\\:\\ 0\\.001375824612334571\ \(0\)\
\-\ relative\\:\\ 0\\.0013728790204395442\ \(0\)\
\-\ variant\\:\\ 0\\.0013728790204395442\ \(0\)\
\-\ unlikely\\:\\ 0\\.0013728790204395442\ \(0\)\
\-\ into\\:\\ 0\\.0013715523561279642\ \(0\)\
\-\ reflexes\\:\\ 0\\.0013641935242835863\ \(0\)\
\-\ able\\:\\ 0\\.0013585250189492252\ \(0\)\
\-\ phase\\:\\ 0\\.001355726097257928\ \(0\)\
\-\ felt\\:\\ 0\\.001355726097257928\ \(0\)\
\-\ iii\\:\\ 0\\.0013529502122203176\ \(0\)\
\-\ current\\:\\ 0\\.0013501969877214436\ \(0\)\
\-\ major\\:\\ 0\\.001347466056782955\ \(0\)\
\-\ period\\:\\ 0\\.001347466056782955\ \(0\)\
\-\ injuries\\:\\ 0\\.0013447570612695437\ \(0\)\
\-\ scans\\:\\ 0\\.0013420696516070895\ \(0\)\
\-\ main\\:\\ 0\\.0013420696516070895\ \(0\)\
\-\ 27\\:\\ 0\\.0013367582327308198\ \(0\)\
\-\ 45\\:\\ 0\\.0013315291647591622\ \(0\)\
\-\ included\\:\\ 0\\.0013289447220119213\ \(0\)\
\-\ regions\\:\\ 0\\.0013188005549841716\ \(0\)\
\-\ muscles\\:\\ 0\\.0013163114800102686\ \(0\)\
\-\ mother\\:\\ 0\\.0013163114800102686\ \(0\)\
\-\ control\\:\\ 0\\.001313840640181576\ \(0\)\
\-\ l\\:\\ 0\\.001313840640181576\ \(0\)\
\-\ lack\\:\\ 0\\.0013113877702560855\ \(0\)\
\-\ r\\:\\ 0\\.001308952610737203\ \(0\)\
\-\ visual\\:\\ 0\\.001306534907709003\ \(0\)\
\-\ subsequently\\:\\ 0\\.001306534907709003\ \(0\)\
\-\ well\\:\\ 0\\.0013039331891862738\ \(0\)\
\-\ 13\\:\\ 0\\.0013017508824166063\ \(0\)\
\-\ arch\\:\\ 0\\.0012970337687657665\ \(0\)\
\-\ numerous\\:\\ 0\\.0012923817208290596\ \(0\)\
\-\ contrast\\:\\ 0\\.0012902365509665466\ \(0\)\
\-\ hemangioma\\:\\ 0\\.0012877929680277852\ \(0\)\
\-\ started\\:\\ 0\\.0012855217935990014\ \(0\)\
\-\ reveal\\:\\ 0\\.001283265811086085\ \(0\)\
\-\ even\\:\\ 0\\.001283265811086085\ \(0\)\
\-\ strength\\:\\ 0\\.0012787986182530259\ \(0\)\
\-\ 14\\:\\ 0\\.0012700379145757037\ \(0\)\
\-\ their\\:\\ 0\\.00126149902486768\ \(0\)\
\-\ life\\:\\ 0\\.0012573093048007132\ \(0\)\
\-\ using\\:\\ 0\\.0012511207251487075\ \(0\)\
\-\ demonstrating\\:\\ 0\\.0012511207251487075\ \(0\)\
\-\ bleeding\\:\\ 0\\.0012511207251487075\ \(0\)\
\-\ resolution\\:\\ 0\\.0012430420603856407\ \(0\)\
\-\ ii\\:\\ 0\\.0012430420603856407\ \(0\)\
\-\ continued\\:\\ 0\\.0012410522721471287\ \(0\)\
\-\ down\\:\\ 0\\.00123710757070929\ \(0\)\
\-\ via\\:\\ 0\\.00123710757070929\ \(0\)\
\-\ \\-\\:\\ 0\\.0012355672571388624\ \(0\)\
\-\ underlying\\:\\ 0\\.0012351523876791633\ \(0\)\
\-\ relatively\\:\\ 0\\.0012332084737780673\ \(0\)\
\-\ but\\:\\ 0\\.0012293445538168889\ \(0\)\
\-\ described\\:\\ 0\\.0012274430662369878\ \(0\)\
\-\ characteristic\\:\\ 0\\.0012199060346376636\ \(0\)\
\-\ and\\/or\\:\\ 0\\.0012180478033354816\ \(0\)\
\-\ general\\:\\ 0\\.0012143617761745404\ \(0\)\
\-\ eye\\:\\ 0\\.001208907186209751\ \(0\)\
\-\ caused\\:\\ 0\\.001208907186209751\ \(0\)\
\-\ outside\\:\\ 0\\.001208907186209751\ \(0\)\
\-\ arm\\:\\ 0\\.0012071084185958007\ \(0\)\
\-\ junction\\:\\ 0\\.0012071084185958007\ \(0\)\
\-\ procedure\\:\\ 0\\.0012071084185958007\ \(0\)\
\-\ mass\\:\\ 0\\.0012024900576197953\ \(0\)\
\-\ position\\:\\ 0\\.0012000077746842216\ \(0\)\
\-\ references\\:\\ 0\\.001198255728519937\ \(0\)\
\-\ recommended\\:\\ 0\\.0011947787067125638\ \(0\)\
\-\ especially\\:\\ 0\\.0011862398170045401\ \(0\)\
\-\ many\\:\\ 0\\.0011845576782149824\ \(0\)\
\-\ occurs\\:\\ 0\\.0011828838875431007\ \(0\)\
\-\ are\\:\\ 0\\.0011786244915982479\ \(0\)\
\-\ upon\\:\\ 0\\.0011779117857767588\ \(0\)\
\-\ at\\:\\ 0\\.0011714298342309945\ \(0\)\
\-\ vessels\\:\\ 0\\.001160283310719168\ \(0\)\
\-\ additional\\:\\ 0\\.0011556312627824612\ \(0\)\
\-\ routine\\:\\ 0\\.0011556312627824612\ \(0\)\
\-\ complex\\:\\ 0\\.0011540947310671626\ \(0\)\
\-\ extensive\\:\\ 0\\.0011525651677736072\ \(0\)\
\-\ 15\\:\\ 0\\.001149526695617666\ \(0\)\
\-\ also\\:\\ 0\\.001136336994043947\ \(0\)\
\-\ vs\\:\\ 0\\.0011347318618552438\ \(0\)\
\-\ change\\:\\ 0\\.0011233462025213637\ \(0\)\
\-\ subsequent\\:\\ 0\\.0011219496451297848\ \(0\)\
\-\ midline\\:\\ 0\\.0011150523060163646\ \(0\)\
\-\ result\\:\\ 0\\.0011056270343837982\ \(0\)\
\-\ cord\\:\\ 0\\.0010951682698837777\ \(0\)\
\-\ course\\:\\ 0\\.0010875316841334373\ \(0\)\
\-\ hospital\\:\\ 0\\.0010850241028560281\ \(0\)\
\-\ activity\\:\\ 0\\.0010812973452888832\ \(0\)\
\-\ compression\\:\\ 0\\.0010788355232040224\ \(0\)\
\-\ 8\\:\\ 0\\.0010776113181279422\ \(0\)\
\-\ appears\\:\\ 0\\.0010727584555808595\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.001070357960549202\ \(0\)\
\-\ with\\:\\ 0\\.0010654680453379504\ \(0\)\
\-\ intact\\:\\ 0\\.0010586052687009161\ \(0\)\
\-\ abnormalities\\:\\ 0\\.0010586052687009161\ \(0\)\
\-\ iv\\:\\ 0\\.0010517453414708579\ \(0\)\
\-\ risk\\:\\ 0\\.0010439145522290342\ \(0\)\
\-\ nerve\\:\\ 0\\.0010384303967916715\ \(0\)\
\-\ they\\:\\ 0\\.0010384303967916715\ \(0\)\
\-\ muscle\\:\\ 0\\.0010351822035164738\ \(0\)\
\-\ hematoma\\:\\ 0\\.00102562120688772\ \(0\)\
\-\ \\&\\:\\ 0\\.0010122724762702973\ \(0\)\
\-\ inflammatory\\:\\ 0\\.0009994320216499238\ \(0\)\
\-\ cerebral\\:\\ 0\\.0009984642501733797\ \(0\)\
\-\ long\\:\\ 0\\.0009936666141088443\ \(0\)\
\-\ 3\\.\\:\\ 0\\.00098612958250952\ \(0\)\
\-\ less\\:\\ 0\\.0009760337282707192\ \(0\)\
\-\ although\\:\\ 0\\.0009733319664676572\ \(0\)\
\-\ first\\:\\ 0\\.0009671107705854476\ \(0\)\
\-\ followed\\:\\ 0\\.0009662313225560781\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.0009592770941571789\ \(0\)\
\-\ white\\:\\ 0\\.0009558530228371055\ \(0\)\
\-\ initial\\:\\ 0\\.0009550024092004412\ \(0\)\
\-\ space\\:\\ 0\\.000953307590919607\ \(0\)\
\-\ out\\:\\ 0\\.0009524633648763966\ \(0\)\
\-\ surrounding\\:\\ 0\\.0009474419104097017\ \(0\)\
\-\ positive\\:\\ 0\\.0009352059326421979\ \(0\)\
\-\ often\\:\\ 0\\.0009195526301921256\ \(0\)\
\-\ 2\\.\\:\\ 0\\.0009165072990894632\ \(0\)\
\-\ follow\\:\\ 0\\.0009157502434895225\ \(0\)\
\-\ between\\:\\ 0\\.0009134892196371817\ \(0\)\
\-\ known\\:\\ 0\\.0009119902477112377\ \(0\)\
\-\ onset\\:\\ 0\\.0009097542077319224\ \(0\)\
\-\ 1\\.\\:\\ 0\\.0009002324338271841\ \(0\)\
\-\ medical\\:\\ 0\\.0008867823946259711\ \(0\)\
\-\ some\\:\\ 0\\.0008751865948960402\ \(0\)\
\-\ only\\:\\ 0\\.0008665806605345482\ \(0\)\
\-\ \\‚\\Ä\\ô\\:\\ 0\\.0008613918177556343\ \(0\)\
\-\ negative\\:\\ 0\\.0008607487896711212\ \(0\)\
\-\ see\\:\\ 0\\.0008601069852373653\ \(0\)\
\-\ demonstrated\\:\\ 0\\.0008456728439989772\ \(0\)\
\-\ infection\\:\\ 0\\.0008377796202606432\ \(0\)\
\-\ loss\\:\\ 0\\.0008365815084210589\ \(0\)\
\-\ level\\:\\ 0\\.0008306539722249349\ \(0\)\
\-\ two\\:\\ 0\\.0008254068255028687\ \(0\)\
\-\ appearance\\:\\ 0\\.0008242517965378217\ \(0\)\
\-\ abnormal\\:\\ 0\\.000821953538048874\ \(0\)\
\-\ fluid\\:\\ 0\\.0008191025647905069\ \(0\)\
\-\ edema\\:\\ 0\\.0008151512611909919\ \(0\)\
\-\ all\\:\\ 0\\.0008151512611909919\ \(0\)\
\-\ shows\\:\\ 0\\.0007923688700603301\ \(0\)\
\-\ presented\\:\\ 0\\.0007856180893836119\ \(0\)\
\-\ if\\:\\ 0\\.0007820382575988653\ \(0\)\
\-\ up\\:\\ 0\\.0007749906074381866\ \(0\)\
\-\ therapy\\:\\ 0\\.0007705365248703585\ \(0\)\
\-\ signal\\:\\ 0\\.0007598901619807011\ \(0\)\
\-\ mild\\:\\ 0\\.0007589387702971795\ \(0\)\
\-\ than\\:\\ 0\\.0007551598161613065\ \(0\)\
\-\ both\\:\\ 0\\.0007359865061335991\ \(0\)\
\-\ more\\:\\ 0\\.000720801453393648\ \(0\)\
\-\ physical\\:\\ 0\\.0007070844079532\ \(0\)\
\-\ associated\\:\\ 0\\.0006800885537631373\ \(0\)\
\-\ present\\:\\ 0\\.0006509304397745972\ \(0\)\
\-\ lower\\:\\ 0\\.0006481828227196839\ \(0\)\
\-\ year\\:\\ 0\\.000644927668986789\ \(0\)\
\-\ multiple\\:\\ 0\\.0006070172018479827\ \(0\)\
\-\ female\\:\\ 0\\.0005924992483803824\ \(0\)\
\-\ seen\\:\\ 0\\.0005695202748963542\ \(0\)\
\-\ images\\:\\ 0\\.0005528714644011312\ \(0\)\
\-\ disease\\:\\ 0\\.0004710750560592594\ \(0\)\
\-\ old\\:\\ 0\\.0002950875537478093\ \(0\)\
